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KRISTIE LYNN BEATON BLADE. Cardiac hypertrophy, heart failure, and regulation 
of microtubule stability. (Under the direction of GEORGE COOPER). 
This work focused on the regulation of the different isotypes of beta-tubulin 
during cardiac hypertrophy, with the specific hypothesis that increased levels of the beta I 
isotype leads to the increase in microtubule density seen during hypertrophy. Partial 
cDNAs for the three beta-tubulin isotypes expressed in the heart (I, II, and IV) have been 
cloned and used to show that there is a differential upregulation of the beta I and beta II 
isotypes during cardiac hypertrophy. Messenger RNA half-life studies of cells isolated 
from hypertrophied myocardium have shown that this upregulation is due to increased 
transcription of the genes encoding those isotypes. This work has also shown the 
presence in terminally differentiated cells of the co-translational autoregulatory 
mechanism by which increased free tubulin protein levels leads to decreased mRNA 
levels. 
The beta-tubulin isotypes that are expressed in the heart have been cloned into 
tetracycline-regulated expression vectors and adenoviral vectors. Overexpression in CHO 
cells has shown that, contrary to some previous reports, overexpression of beta I, beta II, 
and beta IV does not affect microtubule stability as measured by taxol resistance. In 
addition, overexpression of beta I in adult cardiocytes does not affect microtubule 
stability. However, overexpression of the predominant heart microtubule associated 
protein, MAP 4, is alone enough to cause increased microtubule stability in vitro. 
Because there is an increase in MAP 4 protein levels during cardiac hypertrophy in vivo, 
we believe that this is the primary mechanism of increased microtubule stability in the 
hypertrophied myocardium. 
VB 
This work also focused on development of a mouse model in which to study the 
effects of microtubule stability on the development of heart failure in vivo. Mutation of 
the beta-tubulin protein in a string of leucine residues destabilized the microtubules in 
eRO cells. Constructs encoding these mutant tubulin proteins have been inserted into a 
heart-specific vector and cloned into transgenic mice. Several lines have been initially 
characterized for levels of expression, and one line has shown heart-specific expression 
of a mutated beta-tubulin protein. These lines will be used for future studies of the effect 
of destabilized microtubules on the development of heart failure. 
VIl1 
CHAPTER 1: GENERAL INTRODUCTION 
Cardiovascular disease is the number one killer of both men and women in this 
country and a considerable burden, in terms of health care costs, for our economy. Nearly 
60 million Americans have one or more types of cardiovascular disease, with about 4.6 
million Americans suffering from heart failure (American Heart Association statistics). 
There are many different common types of cardiovascular disease, including coronary 
artery disease, hypertension, and valvular diseases; many of them, including those 
mentioned, cause increased load for the heart muscle. The primary response of the 
cardiocyte to increased load on a long-term basis is hypertrophy, or growth in mass. 
Unfortunately, this initially compensatory response to a load increase can eventuate in 
decompensation and heart failure. 
Heart failure is essentially a syndrome characterized by an underlying 
cardiovascular disease that has resulted in decreased ventricular function causing a 
combination of systemic symptoms resulting from reduced cardiac output. There are 
many causes of heart failure including arrhythmias, valve disease, pericardial disease, 
congenital heart disease, and myocardial disease (1). Most cases of heart failure are 
caused by myocardial diseases that include coronary artery disease, cardiomyopathy, 
hypertension, and drug-induced diseases (1). By far the most common causes are 
coronary artery disease and hypertension. In fact, only about 7% of heart failure cases 
cannot be attributed to coronary artery disease, hypertension, and valve disease (2). 
While we know what conditions cause heart failure, and we know the specific signs and 
symptoms of heart failure, we do not know at a molecular level what causes the loss in 
function of the heart muscle during failure. 
We do know that heart failure is usually associated with some form of cardiac 
hypertrophy. Hypertrophy is the compensatory response of the heart to increased load, 
which is caused by the various diseases mentioned above, as well as by non-disease states 
such as exercise and pregnancy. Pressure-induced overload, such as is seen during long-
term hypertension, often leads to concentric hypertrophy of the left ventricle. The 
individual heart cells, or cardiomyocytes, enlarge, increasing the ventricular wall 
thickness in a concentric manner. Because wall stress is proportional to pressure and the 
chamber radius/ wall thickness ratio, the decreasing chamber radius/ wall thickness ratio 
from concentric hypertrophy offsets increased afterload, allowing the wall stress to 
remain normal. During the initial compensatory stages, ejection fraction, which is an 
indication of systolic function, remains normal, but diastolic filling may be impaired due 
to reduced compliance of the thickened ventricular wall. Over time, dilatation of the 
ventricle often occurs, such that the ventricular radius increases and wall stress goes up, 
causing ejection fraction to decrease. This then increases myocardial oxygen 
consumption and leads to decreased ability of the heart to pump (for an excellent review 
of this sequence of events, see (3)). 
Little is known about the molecular mechanisms that underlie the shift from 
compensatory hypertrophy to decompensated heart failure in the presence of continued 
pathologic increased load. More is known about the sequence of events leading to 
compensatory hypertrophy, and many studies in this lab as well as others are now 
focused on the elucidation of the signaling pathways involved in transducing mechanical 
signals into hypertrophic responses in cardiac muscle. It is well known that a mechanical 
stimulus is sufficient to cause hypertrophy at the level of the intact heart, isolated cardiac 
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tissue, and isolated cardiocytes (4). The immediate downstream signals of mechanical 
stimulation are now being studied, and include several members of growth factor, G-
protein, and integrin-coupled signaling pathways (reviewed in (5)). The endpoints of 
these signaling pathways are fairly well characterized and include increased protein 
synthesis rates, increased protein content, specific changes in gene regulation programs, 
and overall growth in size of the cell (for a review of some of these changes, see (6)). 
One of the more noteworthy changes in gene regulation patterns seen during pressure 
overload-induced hypertrophy is the recapitulation of an embryonic pattern of gene 
expression, especially in relation to some of the structural protein isoforms as well as 
some of the ion channels. Although many of the molecular changes during hypertrophy 
and heart failure have been elucidated, the exact cause of the decrease in contractile 
function seen at the whole organ level is not well understood. 
A problem with research of cardiac hypertrophy and heart failure that often 
presents itself is the difficulty of obtaining good models of hypertrophy that mimic what 
is seen in human disease. While it has a very simple function, the heart is a complex 
organ, particularly in terms of complex chamber geometry, making it difficult to model 
as a simple pump. The primary determinant of the heart's structure, in both pathologic 
and non-pathologic states, is the systolic stress, or afterload, to which each chamber is 
subjected. For this reason, different models of hypertrophy exhibit different changes at 
the molecular level, although all display increases in cellular mass and protein content. 
For this reason, it is important to understand the different ways in which hypertrophy can 
occur. 
Immediately after birth, the heart undergoes rapid changes in mass and 
morphology based primarily on the changes in afterload that are present. When the lungs 
are inflated after birth, there is an immediate drop in pressure in the pulmonary arterial 
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circulation. This, coupled with the sudden demands of the systemic circulation in the 
newborn, leads to rapid growth of the left ventricle in comparison to the right, as well as 
closure of the ductus arteriosus. This growth of the left ventricle is due to hypertrophy of 
existing cardiocytes (7). This physiologic hypertrophy is critical for establishing the 
structure of the adult heart and is based solely on the presence of changes in afterload for 
the different chambers. Later in life, the heart continuously adapts to changes in pressure 
in order to maximize function. Physiologic causes of hypertrophy include exercise and 
pregnancy-induced hypertrophy. These adaptive forms of hypertrophy are critical for 
maintaining normal wall stress in the face of increased preload and afterload, and do not 
lead to decreased cardiac function. 
Pathologic causes of hypertrophy, like those mentioned above, often lead to 
decreased cardiac function. However, not all pathology that leads to hypertrophy is alike. 
One major distinction that can be made is hypertrophy due to pressure overload, or 
increased afterload, and hypertrophy due to volume overload, or increased preload. Both 
stressors can cause the cardiocytes to increase their mass, but each leads to different 
pathologies at the cellular and whole organ levels. To study hypertrophy, most labs, 
including this one, choose to use animal models of pressure and volume overload. While 
there are many models available, I will discuss the models that our lab primarily uses. 
These include the feline pulmonary artery band and atrial septal defect models, as well as 
the canine aortic banding model. 
The feline models provide a prime example of the difference between pressure 
and volume overload-induced hypertrophy. The volume overload model is an atrial septal 
defect (ASD) model in which the interatrial septum is resected during venous inflow 
occlusion, creating a volume overload of the right ventricle (RV) and leading to right 
ventricular hypertrophy (8). The pressure overload model is a pulmonary artery band 
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(PAB) model in which the pulmonary artery is constricted by a band, leading to a sudden 
and constant increase in the pressure that the right ventricle must pump against and 
therefore to right ventricular hypertrophy (9). Both models lead to right ventricular 
hypertrophy with no right heart failure, and both have normal left ventricle (LV) weight! 
body weight ratios (10). These models are similar in that they each subject the right 
ventricle to a sudden stress that remains high. The pressure overload model is most 
analogous to the human condition of primary pulmonary hypertension and the volume 
overload model to congenital atrial septal defects. While both models lead to cardiac 
hypertrophy, the ASD model does not cause contractile defects (8), while the PAB model 
leads to contractile defects at both the organ (9) and the cardiocyte (11) levels. 
As discussed above, in humans the bulk of cardiac hypertrophy is LV hypertrophy 
due to ischemic heart disease following coronary artery disease (CAD) and LV 
hypertrophy due to long-term hypertension. In these diseases, the hypertrophying 
stimulus is applied over time, often becoming increasingly worse with time, especially 
with CAD as more tissue becomes ischemic and necrotic. To more accurately model 
these common human diseases, this lab uses a canine aortic banding model of LV 
hypertrophy in which there is a stepwise increase over time in the amount of afterload 
imposed by a supracoronary ascending aortic band (12). The dogs used in this model 
randomly segregate into two sets: the first, a "hypertrophy" group, maintains 
compensated contractile function in the face of a large degree of hypertrophy; the second, 
a "failure" group, shows abnormalities in contractile function over time in the face of a 
lesser degree of LV hypertrophy (12). This model most closely resembles the human 
condition of chronic hypertension, and in fact similar groups are seen clinically in people 
(12). As to contractile dysfunction at the cellular level, only the failure group exhibits 
decreases as measured by extent and rate of sarcomere shortening (13). These are the 
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same dogs in which wall stress, after a certain period, is no longer normalized by 
hypertrophy (12, 13). These dogs then are similar, in this respect, to the PAB cats, in that 
individual cardiocytes from these animals display contractile defects (14), while at the 
same time they probably have uncompensated increased wall stress (G. Cooper, personal 
communication). 
While none of these models closely resembles the most common cause of heart 
failure, ischemic heart disease secondary to CAD, they offer an excellent opportunity to 
study the effects of pressure overload-induced hypertrophy with uncompensated 
increased wall stress, which is present in many patients with CAD. The two pressure 
overload models present a means to study the question of what, at the molecular or 
cellular level, leads to a decrease in contractile function of hypertrophied myocardium 
and hypertrophied cardiocytes during pressure overload-induced hypertrophy. Previous 
studies in this lab have extensively characterized the defects present in the feline RV 
pressure overload model. One study showed that, in PAB cats with contractile 
dysfunction but not ASD cats with no contractile dysfunction, the hypertrophied 
myocardium showed decreased volume density of cardiocytes and increased connective 
tissue (15). While these changes could certainly cause the decreased systolic and diastolic 
function seen in this model, further studies showed that, before the interstitial fibrosis 
becomes substantial, the individual cardiocytes themselves have decreased contractile 
function (11). However, there was no obvious difference in morphology between cells 
isolated from the volume-overloaded and pressure-overloaded RVs (15). 
These observations led to the search for a cellular structure that could interfere 
with contractile function and be responsive to pressure overload, yet not be obvious 
ultrastructurally (14). One candidate structure turned out to be changed during pressure 
overload but not volume overload-induced hypertrophy-the microtubular cytoskeleton 
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(14). In fact, this lab has shown in the feline PAB model that several things concerning 
microtubules are true. There is an increase in microtubule density (14). There is an 
increase in microtubule stability, as indicated both by increased microtubule age and 
increased resistance to destabilizing conditions (10). Finally, the higher density of 
microtubules leads to an increased viscosity in the cardiocyte that decreases the cell's 
ability to contract (16). These observations have been extended to the canine aortic 
banding model. Specifically, it was found that in the failure dogs, which do not normalize 
wall stress and have contractile dysfunction at the cellular level, there is an increased 
density of microtubules (13). Importantly, this lab has shown that, in isolated cardiocytes 
from both the P AB cat R V and the aortic-banded failure dog LV, contractile dysfunction 
is normalized by dissolution of the microtubules (13, 14). These studies collectively show 
that a significant cause of decreased contractility at the cardiocyte level in high wall 
stress states in the cat and dog is densification of the microtubule network. 
A primary objective in this lab soon became to discover why high wall stress in the 
heart could lead to an increased density and stability of microtubules in the cardiocyte. 
This requires an understanding of the structures and their dynamics. Microtubules are 
cytoskeletal elements that have a hollow, tubular structure. Most mammalian 
microtubules are made of 13 protofilaments which are strings of tubulin heterodimers, 
globular proteins made of an u- and B-tubulin. They function primarily as mechanisms 
for guiding movement of various components of the cell, including the chromosomes 
during mitosis, vesicles during membrane transport, and structural proteins in axons of 
neurons. We speculate that in the mature cardiocyte, which no longer undergoes cell 
division, the primary function of the microtubules is structural support of the cell, as well 
as transport of proteins, especially when the cell undergoes growth, or hypertrophy. 
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The a- and B-tubulin proteins are highly conserved proteins that are present in all 
eukaryotes and are therefore very ancient on an evolutionary timescale. The proteins are 
50% identical at the amino acid level (17), and are therefore structurally very similar. 
They each bind a' GTP molecule, but only the B-tubulin-bound GTP is hydrolyzed during 
polymerization of the microtubule. For this reason, the site of GTP binding to the B-
tubulin molecule is called the exchangeable or E-site, and the site of GTP binding to the 
a-tubulin molecule is called the non-exchangeable or N-site. The heterodimers form long 
protofilaments by binding in a linear manner, and the protofilaments aggregate by lateral 
interaction to form 25 nm diameter hollow tubes. The lateral interactions between 
protofilaments occur between like monomers (in other words a to a and B to B) except at 
the seam in a B-type lattice structure (see Figure 1-1). When both ends of a microtubule 
are free, polymerization and depolymerization can occur at both ends, but there is a net 
addition at one end, which is termed the "+" end, and a net subtraction at the other end, 
which is termed the "-" end. Usually in vivo, the "-" end of the microtubule is fixed to a 
stabilizing structure that contains a related protein called y-tubulin. 
Although microtubules are polymers, they do not behave as equilibrium polymers, 
because in steady state they undergo transitions between states of polymerization and 
depolymerization. Microtubule dynamics are governed principally by the concept of 
"dynamic instability," (18) where the polymers alternate between periods of shrinkage, 
called "catastrophe," and periods of growth, called "rescue" (reviewed in (19-21)). 
Therefore, the rate of polymerization, the rate of depolymerization, the frequency of 
catastrophe, and the frequency of rescue all influence microtubule dynamics. Because 
microtubule stability is a nonequilibrium behavior, it requires an energy source, and this 














Figure 1-1. Microtubule structure. Head-to-tail interactions of a~ dimers form linear protofilaments. 
Thirteen linear protofilaments associate laterally to form 25 nm diameter hollow cylindrical polymers 
(MTs). The figure shows a 13 protofilament MT with a B-type lattice with seam, the accepted lattice 
structure for MTs. Lateral interactions between protofilaments are a to a and ~ to ~, except at the seam. 
A seam is formed because one turn of a 3'~start helix results in a rise of 1.5 a~ tubulin dimers (or 3 
tubulin monomers). Plus and minus signs indicate MT polarity and the brackets delineate a~ dimers 
within the MT lattice (adapted from (20)). 
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reviewed in (19), that stabilization of microtubules requires the presence of a GTP cap at 
the + end, as originally proposed in (18). 
Although dynamic instability is active both in vitro and in vivo, there are differences 
In microtubule polymerization kinetics (reviewed in (19)). In particular, the 
polymerization rate of microtubules in vivo is much higher and yet the catastrophe 
frequency is high. Therefore, it is obvious that there are factors at work in the cell 
environment that influence the various dynamic instability parameters. Work in many 
labs has focused on finding these factors, and many of them are reviewed in (19) and 
(20). 
The most extensively studied proteins that affect microtubule stability are the 
microtubule-associated proteins, or MAPs. The fibrous, or non-motor, MAPs are a group 
of homologous proteins that consist of a basic C-terminal microtubule binding domain 
and an acidic N-terminal projection domain. These proteins include MAP 1, MAP 2, tau, 
and MAP 4. Of these, all except MAP 4 are primarily located in the brain. All of these 
proteins promote the assembly of and stabilize microtubules. The primary MAP present 
in cardiac tissue is MAP 4, making it a prime candidate for study in relation to 
microtubule stability in the heart. For this reason, our lab has focused attention on 
changes in MAP 4 regulation in the hypertrophied heart. Specifically, we have found that 
there are increased levels of MAP 4 protein as well as mRNA in the PAB cat RV (10). 
Other proteins that affect microtubule stability include the Xenopus microtubule 
associated proteins, or XMAPs, which usually promote microtubule stability; factors that 
increase the incidence of catastrophe, such as Op18/stathmin and XKCMl; factors such 
as katanin that sever microtubules, making them susceptible to catastrophe; and 
nucleating factors, such as y-tubulin (reviewed in (19, 20)). With the exception of y-
tubulin, this lab has not assayed for the presence of these factors in the heart or for 
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changes in their amount or regulation during pressure overload-induced hypertrophy. The 
protein y-tubulin shows no change in the RV during P AB of the feline (10). 
While it is clear that all of these proteins may affect microtubule stability, we also 
searched for other, more subtle, ways that microtubule stability may be changed during 
pressure overload-induced hypertrophy. In particular, we considered ways that the 
microtubules themselves might be altered to produce changes in the way they interact 
with MAP 4, which we believe is an influential factor on microtubule stability in the 
cardiocyte. Possibilities to be considered include post-translational modifications of the 
tubulin proteins and/or changes in the types of tubulin proteins expressed. Tubulin 
proteins are modified in several different ways, including phosphorylation, tyrosination 
and subsequent detyrosination, polyglutamylation, and polyglycylation (reviewed in 
(22)). Phosphorylation seems to be the only one of these covalent modifications that 
might affect binding to MAPs (23), and it occurs only in the BIll isotype of B-tubulin, 
which is not present in cardiac tissue (24). 
There are several different mammalian isotypes for the a- and B-tubulin proteins, 
each of which is encoded by a separate gene. Because these isotypes are regulated in a 
tissue- and developmentally-specific manner and are highly conserved among species, it 
has been speculated that they may serve different functions. It has been proposed that the 
isotypes may show differential binding of MAPs, since they differ significantly at the 
carboxy-terminal 15 amino acids, which is believed to be the MAP binding region (25, 
26). Therefore, we speculate that a differential isotypic make-up of the microtubules 
themselves might lead to changes in microtubule stability through changes in MAP 
binding. 
The focus of this work was initially on the elucidation of possible mechanisms for 
increased microtubule stability during pressure overload-induced hypertrophy in the 
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presence of high wall stress. In particular, the aim was to answer the question of whether 
or not changes in regulation of the B-tubulin isotypes might directly cause changes in 
microtubule stability. However, further goals of this work included the elucidation of 
regulatory mechanisms involved in controlling tubulin production during cardiac 
development and hypertrophy, observing the possible effects on microtubule stability of 
overexpression of tubulin isotypes in non-cardiocytes, and exploration of possible effects 
of mutagenesis of tubulin proteins on microtubule stability in both cardiocytes and non-
cardiocytes. The overall goal of the project was to explore the importance of the B-tubulin 
protein in the determination of microtubule stability in both terminally differentiated 
cardiocytes and non-terminally differentiated cells. 
To achieve these goals, we designed experiments to address several questions and 
hypotheses. In Chapter 2, we focused our questions on the regulation of the different B-
tubulin isotypes in both cardiocytes and non-cardiac cells. Our first hypothesis was that 
during pressure overload-induced hypertrophy, increased levels of {3-tubulin proteins are 
caused by increased transcription of some of the B-tubulin genes, mimicking the 
developmental regulation of those genes. Our second hypothesis was that the 
autoregulatory mechanism elucidated by Don Cleveland and colleagues, whereby 
increased levels of free tubulin heterodimers lead to instability of the tubulin messages, is 
not active during pressure overload-induced hypertrophy and, possibly, at all in the 
terminally-differentiated cardiocyte. In Chapter 3, we wanted to answer the question of 
whether or not overexpression of different isotypes of B-tubulin could change the stability 
of the cell's microtubules. Our first hypothesis was that, in non-cardiocytes, 
overexpression of different isotypes of B-tubulin would not alone cause increased Taxol 
resistance. Our second hypothesis was that, in the adult cardiocyte, the overexpression of 
the BI-tubulin isotype would cause increased microtubule stability, mimicking what is 
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seen during pressure overload-induced hypertrophy in the heart. In Chapter 4, we 
addressed the question of whether or not certain B-tubulin mutants could confer decreased 
microtubule stability in non-cardiac cells and adult cardiocytes. Our hypothesis was that 
overexpression of B-tubulin mutants could confer Taxol resistance on cultured cells due 
to their ability to decrease microtubule stability. 
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CHAPTER 2: REGULATION OF THE BETA TUBULIN ISOTYPES 
INTRODUCTION 
This chapter focuses on the work that was done to elucidate the changes in 
regulation that occur for the B-tubulin multi gene family during cardiac hypertrophy and 
development. Research in this lab has shown that during pressure overload-induced 
hypertrophy in the PAB feline model, there is an increase in density (14) of the 
microtubule network. It was initially hypothesized that increased density of microtubules 
might be caused by an extending force shifting the equilibrium of the polymer to the 
polymerized state (14,27). However, the fact that the levels of both free and polymerized 
tubulin proteins increased and did so only after hypertrophic growth had begun rather 
than immediately following the stimulus (28), led us to hypothesize that there were 
factors during pressure overload-induced hypertrophy that might lead to increased 
stability of the microtubules themselves (10). Indeed, it was found that during PAB in the 
feline, there is an increased density of microtubules that occurs along with an increased 
level of MAP 4 (10). 
While increased levels of MAP 4 could account for the change in microtubule 
stability, some studies in other cell systems indicate that the correlation may not be so 
simple. In particular, in Chinese hamster ovary (CHO) cells, overexpression of MAP 4 
did not affect microtubule morphology or stability (29). However, other studies have 
shown, for muscle cells, that MAP 4 has a role in differentiation and morphogenesis and 
in the organization of the microtubule array (30). The concomitant increase in free 
tubulin protein levels and MAP 4 protein levels during cardiac hypertrophy was 
intriguing in light of the fact that MAPs are known to be regulated coordinately with 
different B-tubulin and a-tubulin isotypes during neuronal development (31). This led us 
to believe that changes in regulation of specific tubulin isotypes might be occurring 
during pressure overload-induced hypertrophy. 
To test this hypothesis, antibodies specific for the B-tubulin isotypes I, II, III, IVb, 
and V were made and used for Western blotting of proteins isolated from pressure-
overloaded and normal cardiac tissue (24). The predominant B-tubulin species is BIVb, 
and the BI and BII proteins are expressed at low levels in the normal adult heart (24). 
Importantly, however, the BIVb protein remains normal during PAB in the RV, and the BI 
and BII proteins are increased (24). Western blotting with proteins isolated from cardiac 
tissue from various developmental stages of the rat showed that the hypertrophic 
regulation of the different B-tubulin isotypes essentially recapitulated their regulation 
during cardiac development (24). A common theme of hypertrophy, as mentioned before, 
is the upregulation of normally embryonically expressed proteins by increases in 
transcription. Therefore, this led to our first hypothesis: changes in the B-tubulin isotypes 
during pressure overload-induced hypertrophy are due to increases in transcription of the 
genes that encode them. 
Tubulin protein levels are normally regulated by an automatic feedback loop in 
which increased levels of free heterodimers directly decrease tubulin message stability, 
leading to decreased levels of tubulin message (reviewed in (32)). The exact mechanism 
of this autoregulatory action has never been fully explained, but many of the specifics 
were elucidated by Don Cleveland's lab in the 1980's. Early experiments showed that 
when cells were treated with microtubule altering drugs then pulse labeled for newly 
synthesized proteins, if the drug treatment increased unassembled microtubule dimes then 
{X- and B-tubulin protein synthesis decreased. However, if the drug treatment decreased 
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levels of unassembled dimers, u- and B-tubulin protein production increased (33, 34). 
Further, Cleveland's lab showed that direct microinjection of free tubulin dimers in an 
amount equal to 25-50% of the cell's total tubulin levels suppressed new u- and B-tubulin 
protein synthesis (35). This decrease in u- and B-tubulin protein synthesis corresponded 
with a decreased level of both u- and B-tubulin mRNA (36). Cleveland's lab further 
confirmed, in experiments with enucleated cells, that the autoregulation occurs through 
alteration of mRNA stability (37). More experiments showed that only polysome-bound 
mRNA's were involved (38); these mRNA's had to contain coding sequence for the first 
four amino acids and must be translated to at least codon 42 (39). Cleveland then 
proposed a model of tubulin regulation in which free tubulin heterodimers bind directly 
or indirectly to the first four amino acids of a tubulin protein that is being actively 
transcribed from a polysome-bound mRNA, causing degradation of the mRNA by an 
unknown mechanim (32). In our model, however, we consistently see increased levels of 
both free tubulin protein as well as tubulin mRNA (28). This observation led to our 
second hypothesis: the autoregulation of B-tubulin message stability by free tubulin 
heterodimers does not occur in the terminall y differentiated adult cardiocyte. 
To explore transcriptional regulation of the B-tubulin isotypes we used isotype-
specific probes and Northern analysis to determine the levels of the B-tubulin mRNAs 
before and after pressure overload-induced hypertrophy. In addition, we explored 
possible cell culture systems to allow us to investigate directly the transcriptional 
regulation of the B-tubulin promoters. Finally, to study the autoregulation of tubulin 
message stability, we used freshly isolated neonatal and adult cardiocytes in combination 




Cloning of 3' UTRs of 131,1311, and 13IV tubulin cDNAs. A diagram of the cloning strategy 
is shown in Figure 2-1. For BI and BIV, the oligos RBTCRI and T7 were used for first 
round PCR from a feline heart cDNA library. Specifically, 1 III of a Ix 1010 PFU/ ml 
feline heart cDNA library (Stratagene, La Jolla, CA) was amplified in the presence of 200 
IlM dNTPs, 4mM MgCI2, 1 IlM each primer, Ix Taq polymerase buffer and 5 units Taq 
DNA polymerase (Gibco BRL, Gaithersburg, MD). The reaction was cycled as follows: 
4 minutes at 94 0 C; 5 cycles of 45 seconds at 94 0 C, I minute at 55 0 C, and I minute at 
72 0 C; 30 cycles of 45 seconds at 94 0 C, 1 minute at 48 0 C, and I minute at 72 0 C; and 
10 minutes at 72 0 C, in a Perkin Elmer Cetus DNA Thermal Cycler (Perkin Elmer, 
Foster City, CA). Eighteen III of the reaction was electrophoresed on a 2% agarose TBE 
gel, denatured, and transferred for southern blot analysis with end-labeled BTCONS 
oligo. An approximately 500 bp positive band was seen (data not shown). Another gel 
was run and this band was stabbed with a pipet tip and used for another round of PCR 
using the same conditions as above with the oligos BTCONS and T7. The product was 
electrophoresed on a gel and showed a predominant band of around 350 bp (data not 
shown). Fifty tt! of the PCR product was cleaned using a Promega (Madison, WI) Wizard 
peR Prep kit, and the cleaned product was used for ligation into Novagen's (Madison, 
WI) PT7 Blue T-Vector. The ligations were transformed into DH5a cells (Gibco BRL), 
mini-preps were done on several of the clones (Promega Wizard Mini-Prep kit), and the 
clones were confirmed by sequence analysis (Sequenase, USB, Cleveland, OH). 
For BII, RTPCR was performed on total RNA isolated from cat brain using a 
modified version of the 3' RACE .protocol described previously (40). Specifically, 2 Ilg 
of cat brain total RNA was denatured at 70 0 C with 20 pmol RTPCRI primer and put on 
ice for I minute. The denatured RNA was then incubated at roomtemperature for 10 
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Figure 2-1. Cloning strategy for the feline tubulin partial cDNAs. PCR of a cat heart cDNA library or 
RTPCR of total RNA from cat brain tissue was used as outlined in the Methods section. The black box 
corresponds to the C-terminal amino acid isotype-defining region for each clone (the amino acid se-
quence for each isotype is shown below). The CRI primer refers to the RBTCRI primer mentioned in 
the text and the CR2 refers to the BTCONS. Both are sense primers from the highly conserved region 
just upstream of the isotype-defining regions. The RTPCR primer refers to the RTPCRI primer men-
tioned in the text; another primer called RTPCR2 in the text corresponds to the non-poly A portion of 
this primer. Both are anti-sense primers and their sequences are given in (24). The S and AS primer sets 
were all isotype-specific and were used to amplify the cloned cDNAs in the presence of radioactively 
labelled dCTP to make double-stranded probes for northern analysis. The figure is not drawn to scale. 
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minutes, 43 0 C for 50 minutes, and 70 0 C for 15 minutes with 200 units of Superscript II 
reverse transcriptase (Gibco BRL), 20mM Tris-HCI (pH 8.4), 50mM KCI, 25mM MgCI2, 
2 f.Lg bovine serum albumin, 0.5mM of each dNTP, and 10mM DTT in a 20 f.LI volume. A 
similar reaction was run without reverse transcriptase to rule out contamination with 
genomic DNA. The cDNAs were treated at 37 0 C for 20 minutes with 2 units of RNAse 
H (Gibco BRL) and diluted to 50 J-tl with dH20. Ten f.LI was then amplified in the 
presence of 200 J.tM dNTPs, 4mM MgCI2, 1 J.tM each of RBTCRI and RTPCR2, Ix Taq 
polymerase buffer, and 5 units Taq DNA polymerase (Gibco BRL) as follows: 5 minutes 
at 94 0 C; 30 cycles of 40 seconds at 94 0 C, 2 minutes at 52 0 C, and 3 minutes at 72 0 C; 
and 15 minutes at 72 0 C in a Perkin Elmer Cetus DNA Thermal Cycler (Perkin Elmer). 
Eighteen J.tl of each reaction was then run on a 1 % TBE gel and transferred overnight for 
Southern analysis with end-labeled BTCONS. A 450 bp band from the reaction 
containing reverse transcriptase hybridized to the radioactive probe, confirming the 
presence of a B-tubulin eDNA. No band lit up in the no reverse transcriptase reaction 
(data not shown). One J.tl of each reaction was then used for a second round of 
amplification using the BTCONS and RTPCR2 primers. Eighteen J.d was run on a 1.6% 
gel, and a prominent 300 bp band was seen (data not shown). Sixty J.tl of this PCR 
product was cleaned using the Wizard PCR Prep kit from Promega, and 4 J.tl of the 
cleaned product was ligated into the PT7Blue T -vector and transformed into DH5a cells. 
Several transformants were sequenced, and the presence of a 811 clone was confirmed. 
Southern blot analysis. Tris-borate-ethylenediamine tetraacetic acid agarose gels were 
depurinated 15 minutes in 0.25N hydrochloric acid, denatured 15 minutes in O.5N sodium 
hydroxide/ 1.5M sodium chloride, and equilibrated 15 minutes in 1M tris pH 7.5/ 1.5M 
sodium chloride. They were then transferred with capillary transfer using lOx sodium 
chloride/ sodium citrate buffer onto a Duralon membrane (Stratagene). End-labeled oligo 
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probes were made by incubating 1 pmol of oligo with 15 units of T4 polynucleotide 
kinase (Promega) and 25 JLei of a 32p_dA TP in 25 JLl of Ix T4 PNK buffer. 
Ligations. For all ligations, a 10: 1 molar ratio of insert to vector was used with 50 ng of 
vector. Ligations were performed overnight at 12-16°C with 3 units of T4 DNA Ligase 
(Promega), IX Ligase buffer, ImM ATP, and IOmM DTT in a 10 J..ll volume. One or two 
JLl were then transformed into 50 JLl DH5a. Subcloning Efficiency competent cells using 
the manufacturer's protocol (Gibco BRL). 
Right ventricular pressure overloading. Pressure overload hypertrophy of the feline right 
ventricle (RV) was created by placement of a 2.9 mm inner diameter band around the 
proximal pulmonary artery (9). Because the RV mass increase stabilizes by 2 weeks after 
a step increase in load (28), at 2 weeks after surgery intravascular pressures were 
measured in these and in control cats. Values in the systemic circulation were the same 
for both groups. At 2 weeks, RV systolic pressure was doubled, and there was a 59% 
increase in the ratio of RV to body weight; the mass of the normally loaded same animal 
control left ventricle (LV) was unchanged. At various time points after the start of 
pressure overload, the hearts were removed, RV mass was determined, and tissue was 
isolated from both the RV and LV free wall. Alternatively, after the hearts were removed, 
Ca2+ -tolerant quiescent cardiocytes were isolated enzymatically from the RV and LV 
separately (41). All operative procedures were carried out under full surgical anesthesia; 
all procedures and the care of the cats were in accordance with institutional guidelines. 
Northern blot analysis. Isotype specific oligonucleotides were used to amplify the 3' 
untranslated regions of each cDNA by PCR in the presence of a_32p labeled dCTP. These 
labeled probes were then used for ~orthem blot analysis of total RNA isolated from the 
left and right ventricles of normal and pulmonary artery banded cats, as well as RNA 
from various other tissues isolated from a normal cat. Total RNA was isolated from the 
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RV and LV of the same hearts and from various tissues (42). The RNA samples were 
dissolved in 500 pJ of diethylpyrocarbonate-treated water and quantified 
spectrophotometric ally at a 260/280 nm extinction coefficient. To assess RNA quality 
and to assure equal loading of RV and LV RNA for Northern blots, 3-5 f.,tg RNA samples 
were stained with ethidium bromide and run on 1 % agarose check gels. We then 
electrophoresed 5-7 f.,tg RNA samples on denaturing 2% formaldehyde, 1 % agarose gels 
followed by 1.5 hours of pressure driven blotting or overnight capillary driven blotting to 
nylon membrane (Duralon, Stratagene). Alternatively, 5 Ilg of total RNA was applied by 
vacuum directly onto a nylon membrane using a slot-blotting apparatus (Schleicher & 
Schuell, Keene, NH). The RNA was immobilized on the nylon membrane by UV cross-
linking (Stratalinker, Stratagene). The membrane was prehybridized for at least 1 hour at 
42°C in a solution containing 500/0 (v/v) deionized formamide, 0.20/0 (w/v) Ficoll, 0.02% 
(w/v) polyvinylpyrrolidone, 6x SSC, 5% (w/v) dextran sulphate, 100 f.,tg denatured 
salmon sperm DNA, and 0.1 % (w/v) SDS. The membrane was then hybridized in the 
same solution with at least 10 million CPMI ml of denatured probe for 12-24 hours at 
42°C. The blots were then washed two times with 2x SSC/ 0.1 % SDS for 20 minutes, and 
once with 0.2x SSC/ 0.1 % SDS at 42°C. Finally, they were washed with 0.2x SSC/ 0.1 % 
SDS at 60°C for 15 minutes and processed for autoradiography. Each RV versus LV blot 
was probed with BII, SI, and SIV sequentially, and was stripped in between each probing. 
Finally, each blot was stripped and probed with a glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) probe PCR-generated from feline GAPDH cDNA. 
mRNA stability. Hearts were removed from control cats and from cats 2 weeks after RV 
pressure overloading. Cardiocytes isolated enzymatically (41) from the RV and LV 
separately were incubated at 37°C in 1.8 mM Ca2+ mitogen-free M-199 medium at pH 
7.4. The cardiocytes were either untreated or exposed to 5 Ilg/ml actinomycin D for 0, 4, 
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8, or 18 hours. To test the effect of an acute increase in the cytosolic concentration of 
tubulin heterodimers on tubulin mRNA stability, further control and hypertrophied 
cardiocytes were simultaneously exposed to both 5Jlg/ml actinomycin D and 10 p.M 
colchicine for 0 or 4 hour. Total RNA was then extracted from the cells for Northern blot 
analysis using the three isotype-specific B-tubulin probes or a probe that recognizes the 
isotype-common region of feline B-tubulin mRNA (28). 
Phenylephrine treatment o/rat neonatal cardiocytes. Primary cardiocytes were obtained 
from day 2-3 neonatal rats by previously published methods (43, 44). Briefly, ventricular 
myocardium was isolated from 40-50 neonatal rats. The tissue was finely minced, rinsed, 
and placed in a suspension culture flask. A mixture of 2.4 units/ml partially purified 
trypsin, 2.7 units/ml chymotrypsin, and 0.94 units/ml elastase in calcium-and 
magnesium-free Hanks' salt solution buffered with 30 mM Hepes, pH 7.4, was 
repeatedly added to the suspension culture flask for six 20-minute incubations at 37° C to 
dissociate the cardiocytes. After each incubation, dissociated cells were centrifuged at 
500xg and resuspended in modified Eagle's medium supplemented with 100/0 newborn 
calf serum (Gibco BRL). To enrich for cardiocytes, the cells were pooled and subjected 
to differential plating for 90 minutes. Cardiocytes were plated at a density of 1 X 106 
cardiocytes per 100 mm dish and maintained overnight in modified Eagle's medium 
supplemented with 10% newborn calf serum, antibiotics (Penicillin 100U/ml, 
Streptomyocin 100 Jlg/ ml, and Amphotericin B 0.25 Jlg/ml), and essential and non-
essential amino acids (Gibco BRL). The next day, the cells were switched to serum-free 
supplemented medium. Cells were treated with 100 JlM phenylephrine or 10 p.M 
verapamil for 48 hours. Cells were then rinsed 2x with ice-cold PBS, pH 7.4, and RNA 
was isolated (42). 
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Western blot analysis oftubulin isotypes. Proteins were transferred from SDS-PAGE gels 
at 100 V for one hour to a PVDF membrane (Millipore, Bedford, MA). The membranes 
were then blocked for one hour at room temperature with 10% (w/v) non-fat dry milk in 
tris-buffered saline/ 0.1 % (v/v) Tween-20 (TBST). Next, the membranes were incubated 
with antibodies to the B-tubulin isotypes (24) in TBST + 1 % (w/v) non-fat dry milk 
overnight at 4°C or 2 hours at room temperature. Additionally, an antibody that detects 
all J3-tubulin isotypes was used (Amersham, Arlington Heights, IL). The antibody 
concentrations used were 1:10,000 for SIV and SII, 1:5,000 for BI, and 1:3000 for the 
common S-tubulin antibody. After several washings with TBST, the blots were incubated 
in 1 % (w/v) non-fat dry milk in TBST with horseradish peroxidase-conjugated secondary 
antibodies (Dupont NEN, Boston, MA). The blots were then detected with ECL reagent 
(Dupont NEN) and subjected to autoradiography. 
Skeletal muscle development oftubulin. To confirm that tubulin isotype expression during 
skeletal muscle development was similar to expression during cardiac muscle 
development, Western blotting of total protein from neonatal and adult rat skeletal 
muscle tissue was used. The hamstring muscles of a I-day old neonatal and an 8-month 
old adult rat were isolated and flash frozen in liquid nitrogen. One hundred mg of tissue 
was homogenized in 2 ml of boiling lysis buffer (1 % (w/v) SDS, 1 mM sodium 
orthovanadate, 10 mM Tris HCI, pH 7.4, and 0.5 mM DTT) for about 1 minute with a 
tissue homogenizer (Tekmar, Cincinnati, OR). The homogenized samples were then 
boiled for an additional 5 minutes and spun at 14,000 RPM in an Eppendorf tabletop 
microfuge for 15 minutes. The supernatant was transferred to clean tubes and protein 
concentrations were determined using a bicinchoninic acid assay system (Pierce, 
Rockford, IL) according to manufacturer's protocol. Equal amounts of total protein from 
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neonatal and adult tissues were electrophoresed on a 10% tris-glycine pre-cast acrylamide 
gel (Novex, San Diego, CA). 
Differentiation of C2C12 myoblasts. C2C12 myoblasts were purchased from ATCC 
(Rockville, lvlD) and cultured according to supplier's protocol. Specifically, cells were 
grown in Dulbeco's modified Eagle's medium (DMEM) with 10% fetal bovine serum 
and antibiotics (Penicillin 100U/ml, Streptomyocin 100 J.Lg/ ml, and Amphotericin B 0.25 
Ilglml). When cells were at least 80-90% confluent, the serum medium was removed and 
replaced with DMEM +2% horse serum. After 3-9 days, cells were scraped in lysis buffer 
(see above) and total protein was isolated. Total protein was also isolated from non-
differentiated cells, protein concentrations were determined as above, and equal amounts 
of protein from myoblasts and myotubes were subjected to SDS-PAGE. Western blotting 
was performed with the B-tubulin antibodies as described above. 
Treatment of cardiocytes with colchicine. Neonatal and adult cardiocytes were isolated as 
described above. The cells were plated and treated in maintenance medium with 10 J.LM 
colchicine or vehicle for 12 hours. The adult cardiocytes were treated in either the 
presence or absence of 10-7 M insulin. 
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RESULTS 
Previously, this lab has shown increased free and polymerized tubulin protein 
levels during pressure overload-induced cardiac hypertrophy (28, 45). We hypothesized 
that this was due to increased transcription of the tubulin genes. However, there are at 
least ten different genes that encode the various a- and S-tubulin isotypes, leaving the 
possibility that only some of the genes are upregulated. Studies with isotype-specific B-
tubulin antibodies generated in this laboratory showed that, indeed, only some of the B-
tubulin isotypes are increased during pressure overload-induced hypertrophy. 
Specifically, the normally embryonically expressed isotypes, BI and BII, are increased in 
both the free and polymerized microtubule fractions in pressure-overloaded myocardium, 
whereas the predominant adult isotype, SIV, remains unchanged (24). 
To test the hypothesis that increased gene transcription causes increased protein 
levels for the different tubulin isotypes, we used Northern analysis of PA-banded cat 
tissue. The largest non-conserved sequences present in the B-tubulin genes are the 3' 
untranslated regions (UTRs), which differ from isotype to isotype and from species to 
species. Therefore, it was first necessary to clone the 3' UTRs of each cDNA from the 
cat in order to generate isotype-specific probes. Figure 2-1 shows the strategy that was 
used to clone the partial cDNAs (see Methods). For BI and BIV, we used oligonucleotides 
specific for the 3' end of the conserved region of the genes and 3' vector sequence to 
amplify B-tubulin 3' UTRs from a feline heart cDNA library. For BII, we used the 
conserved region oligos and oligo-dT for RTPCR of total cat brain RNA. PCR products 
were then cloned and sequenced. Isotype-specific probes were generated using peR to 
amplify and radioactively label only the 3' UTRs. We ran the templates on a gel and used 
Southern analysis with each probe to determine the washing conditions that would ensure 
specificity of each probe (data not shown). Northern analysis of total RNA from various 
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tissues was used to determine if the probes were indeed isotype-specific. Figure 2-2 
shows that the expression of the different isotypes in the cat is consistent with previous 
tissue studies done in the mouse (46, 47), indicating that the probes are isotype-specific. 
Additionally, Sl, which has an alternate polyadenylation site and therefore two different 
transcripts (48), was the only probe which hybridized to two bands, further indicating the 
probes' specificity. 
The data from Northerns performed with RNA from hypertrophied versus normal 
tissue show that there is some increase in the levels of all heart S-tubulin isotypes during 
pressure overload-induced hypertrophy (Figure 2-3). The changes in RNA levels peak at 
48 hours of pressure overload and have not returned to basal levels even after 2 weeks of 
pressure overload. However, qualitatively the data show that the changes in Sl and BIl 
seem to be much greater than the change seen in SIV. Densitometry performed on slot 
blots from two different 48 hour cats shows that there is at least a two-fold greater 
increase in the levels of BI than in the levels of SIV during hypertrophy (Figure 2-4). The 
data confirm that the greater amounts of BI and BII proteins seen during pressure 
overload-induced hypertrophy are indeed due to increases in the levels of the messenger 
RNAs encoding those proteins. 
To test the hypothesis that changes in the tubulin mRNA levels are due to 
transcriptional regulatory mechanisms, we checked whether or not there are any changes 
in message stability in the normal versus hypertrophied cardiocyte. The isotype-specific 
probes were used to determine message stability for each of the S-tubulin mRNAs in 
hypertrophied cardiocytes isolated from the PA-banded adult felines. Figure 2-5 shows 
that, while the half-life of each B-tubulin isotype's mRNA is different, the half-lives are 
the same in the normal and pressure-overloaded cardiocytes from the P AB cat (24). This 
data qualitatively shows no large changes in the half-lives of the B-tubulin isotypes. This 
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Figure 2-2. Tissue distribution of ~-tubulin isotypes. These northern blots show the tissue distribution 
in the cat of the 3 ~-tubulin isotypes which are expressed in the heart. Total RNA was isolated, run on 
a 1 % agarose gel, transferred to nylon membranes, and probed with radioactively labeled probe as 
discussed in the methods. The pictures underneath show the ethidium bromide-stained gels before 
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Figure 2-3. Tubulin isotype mRNA in PAB cats. These northern blots were made with total RNA 
isolated from the left and right ventricles of PA banded cats. The bands were left from 48 hours to 2 
weeks before the cats were sacrificed, as indicated above the blots. The blots were stripped and re-





































ALL BETAS BETA I BETA IV 
Figure 2-4. Densitometry of isotype mRNA levels in 48 hour PAB cats. Different amounts of total 
RNA from the LV and RV of 48 hour PAB cats were loaded on a slot blot apparatus and probed with the 
common ~-tubu1in, ~I, and ~IV isotype probes. Sample blots from 1 cat are shown. Densitometry was 
performed on one cat using the NIH Image program, and values in the linear range of the concentration 
blot were used to obtain the average values for the RV / LV ratio as shown in the graph. 
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Figure 2-5 . Half-life studies of the ~-tubulin RNA. These northern blots show the resuls of half-life 
experiments done in the adult feline. Right ventricular and left ventricular cardiocytes were isolated 
from a 2-week PAB cat and treated with actinomycin D in suspension in cell media to arrest mRNA 
synthesis for 18 hours. Total RNA was isolated after 1=0 hours, 2=4 hours, 3=8 hours, and 4=18 hours 
of actinomycin D treatment. Lanes 5 and 6 show cardicytes incubated with both colchicine and actino-
mycin D for 0 and 4 hours respectively. 
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indicates that while there may be a contribution from increased RNA stability, the bulk of 
the mRNA increase comes from increased production. However, definitive proof of this 
hypothesis must come from quantitative comparisons of the mRNA level changes to the 
mRNA half-lives and from direct observations of increased promoter activity in 
transfection experiments. 
An obvious next step in elucidating the mechanisms responsible for upregulation 
of specific B-tubulin isotypes during pressure overload-induced hypertrophy would be to 
explore the activity of the promoter regions of these genes in a system that mimics the 
changes seen during hypertrophy. The regulation of these genes is intriguing because, as 
for many other genes during hypertrophy, it is the reverse of the regulatory pattern seen 
during development (24). If the mechanism of regulation is similar in both hypertrophy 
and development, this widens the options available for cell models in which to study the 
promoter activity of these genes. Therefore we can consider not only models of 
hypertrophy, but also those of mesodermal development. For this reason, we screened 
several cell models for changes in the B-tubulin isotypes that mimicked those of pressure 
overload-induced hypertrophy. 
The first model chosen was the one most commonly used in the literature, the 
neonatal rat primary cardiocyte. The cells can be easily isolated, cultured, and transfected 
with plasmid DNA. Neonatal rat cardiocytes undergo hypertrophy in several different 
ways, including stimulation with a-adrenergic agonists, such as phenylephrine, as well as 
growth factors, such as IGF-1, angiotensin II, endothelin I, and others (6). In addition, 
hypertrophy can be induced by electrical stimulation (49) and mechanical stretch (5). All 
of these manipulations increase the size of the cells, lead to a more organized myofibrillar 
structure, and cause the upregulation of many genes normally stimulated during 
hypertrophy. We therefore assessed the difference in B-tubulin mRNA levels between 
31 
neonatal cardiocytes treated with an a-adrenergic agonist, phenylephrine, and cells 
whose contraction was arrested by a calcium channel blocker, verapamil. Primary rat 
neonatal cardiocytes were cultured without serum for 2 days and then treated with 
phenylephrine or verapamil for 48 hours before being lysed for total RNA isolation. The 
RNAs were then subjected to Northern analysis with a probe that hybridized to all 8-
tubulin rnRNAs. Figure 2-6 shows a representative slot blot from 1 experiment in which 
cells were treated for 48 hours and summary data from densitometric analysis of 3 similar 
experiments. Clearly, there is a consistent increase in the levels of B-tubulin mRNA in 
phenylephrine- versus verapamil-treated cells. However, this increase is not nearly as 
much as that seen in pressure-overloaded myocardium. Similar small changes were also 
seen with angiotensin and endothelin-l, both of which are known to stimulate 
hypertrophy in cultured neonatal rat cardiocytes (data not shown). Because such small 
changes in transcriptional activity are difficult to reproducibly study, we decided to 
explore models of mesodermal differentiation. 
There are several skeletal muscle cell lines available that show differentiation 
from myoblasts to multinucleate myotubes upon withdrawal of serum. To confirm that 
the changes in B-tubulin gene regulation during skeletal muscle development correlate to 
those seen in cardiac muscle development, we isolated total proteins from skeletal muscle 
tissue from neonatal and adult rats and did Western blots with the 81, Bll, and BIV 
antibodies. Figure 2-7 shows that there is a large decrease in the levels of Bl and Bll, and 
an increase in the level of 81V from the neonatal to the adult rat. This agrees with 
previous data we obtained from mouse cardiac tissue (24), making a differentiating and 


































Figure 2-6. Treatment of neonatal rat cardiocytes with phenylephrine. The graph shows summary data 
from 3 experiments showing a small but consistent increase in the levels of ~-tubulin mRNA in cells 
that were treated with the a-adrenergic agonist phenylephrine versus cells whose spontaneous contrac-
tion was arrested by verapamil. The inset shows a slot blot analysis from one experiment where differ-
ent amounts of RNA were loaded to better quantify the signals in a linear range. 
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Figure 2-7. Levels of the ~-tubulin isotypes in skeletal muscle tissue. Total protein was isolated from 
skeletal muscle tissue of neonatal (N) and adult (A) rats. Western blots were performed with the ~I, ~II, 
and ~IV isotype antibodies. The data show that the isotypes have the same distribution in skeletal 
muscle tissue that they have in cardiac tissue. 
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To explore this option, we cultured a readily available cell line, the C2C 12 mouse 
skeletal muscle cell line, in serum. Upon serum withdrawal from 100% confluent cells, 
the cells fused and formed large, multinucleate myotubes. However, about 30-50% of the 
cells remained as mononucleate myoblasts, and the myotubes that did form did not show 
extensive sarcomeric organization. We isolated total protein from both serum-starved and 
undifferentiated cells, and did Western blotting to look for changes in the tubulin 
isotypes. Figure 2-8 shows the results of Western blots probed with the BI, BII, BIV, and 
common B-tubulin antibodies. As in skeletal muscle tissue, the BI tubulin isotype does 
decrease during differentiation. However, SIV is expressed at high levels in the 
undifferentiated cells and SII is expressed at high levels in differentiated cells. This and 
the high level of expression for BI in the differentiated cells are contrary to what occurs in 
both embryonic and adult skeletal muscle and cardiac muscle tissue. 
It is our suspicion that the serum-starved C2C12 cells are not homogenously 
differentiated to a point where they have the same pattern of B-tubulin isotype expression 
that is present in adult tissue. We attempted to find conditions that would improve the 
percentage of fully differentiated cells. We tried addition of certain growth factors, such 
as insulin and low percentages of serum, removal of thyroxine, and electrical stimulation 
(50). While many of these manipulations improved the percentage of differentiated cells, 
none caused a complete switch from the embryonic to the adult pattern of B-tubulin 
isotype expression that is seen in skeletal and cardiac tissue. We later tried using other 
skeletal muscle cell lines as well as different C2C 12 subclones, but none will differentiate 
in culture to a point where the B-tubulin isotype expression mimics that of adult tissue. 
We are exploring other mesodermal cell lines in an attempt to find a suitable cell model 
for the study of the B-tubulin promoters. 
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Figure 2-8. ~-tubulin isotype levels in differentiating C2C12 cells. Total protein was isolated before 
and after serum starvation from cultured myoblasts and myotubes, respectively. Western blots were 
performed with antibodies to all the ~-tubulins (common ~, C~) and the different isotypes. The data 
are different than those that were obtained for skeletal muscle tissue (see Figure 2-7), especially for 
the ~II isotype. 
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In the pressure overloaded right ventricle of a P AB cat, there is both an increase 
in the levels of free tubulin protein and the message for that protein (24, 28). This raises 
an intriguing dilemma about the regulation of the B-tubulin genes. Specifically, the most 
extensively studied mechanism of tubulin regulation to date has been the autoregulation 
of message stability by free tubulin protein (reviewed in (32». According to this model, 
free tubulin heterodimers either directly or indirectly bind to the amino terminus of the 
tubulin protein as it is being translated, leading to increased degradation of the ribosome-
bound message. In the pressure-overloaded myocardium, we consistently see increases in 
both free tubulin protein and tubulin message levels, which seems to contradict this 
regulatory mechanism. As we showed in Figure 2-5, while the free tubulin protein levels 
are increasing during hypertrophy, the message stability remains constant. This brings 
forward the possibility that the most well-studied regulatory mechanism for tubulin 
expression is not a key player in the regulation of tubulin expression in the heart. 
To first test the hypothesis that this regulatory mechanism is not used in the 
normal cardiocyte, we treated both neonatal rat cardiocytes and adult feline cardiocytes 
with colchicine to rapidly depolymerize the microtubules and, therefore, cause an 
increase in free tubulin heterodimers. Northern analysis showed there was decreased 
tubulin mRNA after colchicine treatment in the neonatal cardiocyte, but not the adult 
cardiocyte (Figure 2-9). This led us to wonder if the autoregulation of message stability 
was not present in a fully differentiated cell. However, half-life studies in which 
cardiocytes were treated with colchicine and actinomycin D seemed to contradict this, as 
we saw a rapid decrease of B-tubulin message (see Figure 2-5). Since the autoregulatory 
mechanism relies on active protein synthesis, we repeated the colchicine studies in the 
adult cardiocytes using insulin as a stimulus for protein synthesis. In the presence of 
insulin, colchicine causes a rapid decrease in tubulin message, also shown in Figure 2-9. 
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NEONATAL CARDIOCYTES ADULT CARDIOCYTES 
Insulin + + 
Controls 10JlM Colchicine Colchicine + + 
Figure 2-9. Autoregulation of tubulin message stability in neonatal and adult cardiocytes. Total RNA 
was isolated from cultured cardiocytes that had been treated with or without colchicine or insulin. 
These northems were probed with the common tubulin probe and show that both neonatal and adult 
cardiocytes display decreased levels of J3-tubulin mRNA in the presence of large and rapid increases in 
the levels of free tubulin heterodimers. Colchicine treatment was for 12 hours. 
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We believe, therefore, that this regulatory mechanism can be present in terminally 
differentiated cardiocytes, but that it might require stimulation of protein synthesis to 
occur simultaneously with a rapid depolymerization of the microtubules. It is also 
possible, however, that insulin, through its activation of protein kinases, might be 
regulating some co-factor required for this autoregulation in the terminally-differentiated 
cardiocyte. We propose, however, based on the fact that free tubulin protein levels can 
increase without causing a decrease in message stability, that this regulatory mechanism 
might be rate-dependent. In other words, rapid changes in free tubulin levels, as are seen 
just before spindle apparatus formation in mitotically active cells, might be required to 
activate this mechanism. 
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DISCUSSION 
Hypertrophy is the primary response of the adult heart to increased load; it 
involves an increase in protein synthesis rates and protein levels to promote growth and 
enlargement of cells that are incapable of mitosis. However, rather than just an overall 
increase in synthesis rates, hypertrophy involves a very finely orchestrated series of 
changes in both translational and transcriptional regulation that leads to a phenotype 
distinct from normal cells. Some changes in gene transcription have well-known 
functional consequences. For instance, the gene for a ribosomal transcription factor, 
UBF, that activates transcription of rDNA is upregulated during hypertrophy of cultured 
neonatal cardiocytes, an important step for the ribosome biogenesis needed for 
hypertrophy (51, 52). However, most changes in gene transcription during hypertrophy 
have less characterized effects. Study of transcriptional changes during cardiac 
hypertrophy are confounded by the fact that they vary from model to model and species 
to species (for a review of changes in gene transcription during cardiac hypertrophy see 
(6»). 
One pattern that has emerged is the re-expression during cardiac disease of genes 
that are normally only expressed during development or differentiation. One classic 
example is the switch in expression of the myosin heavy chain (MHC) isoforms during 
hypertrophy in the rodent (reviewed in (6»). Normally, the adult rat ventricle expresses 
mostly the uMHC isoform, an isoform that has a faster ATPase activity than the 
predominantly expressed fetal BMHC isoform. However, during pressure overload-
induced hypertrophy (but not exercise, hyperthyroidism, or volume overload-induced 
hypertrophy), the rat cardiomyocyte begins to express the BMHC isoform. This has 
functional significance in that it slows the ATPase activity and allows for a slower, more 
productive contraction (6). This isoform switch was not believed to occur in humans 
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largely because the predominant adult MHC in humans is already BMHC. However, more 
recent data using quantitative RT-PCR has shown that, at an RNA level at least, there is a 
substantial amount of a-MHC expression in normal human hearts and that this 
expression drops to almost nothing in failing human heart tissue (53, 54). 
In light of past evidence showing a re-expression of fetal isoforms of some 
proteins during pressure overload hypertrophy, it was not surprising to find this 
phenomenon for the B-tubulin isotypes. In fact, it was a somewhat welcome finding, 
because it presented a great opportunity to study non-cardiac specific genes and their 
developmental regulation. The tubulin isotypes are regulated developmentally in other 
tissues as well as heart, affording an opportunity to study more basic questions about 
terminal differentiation. For instance, during brain development the BII tubulin gene has a 
3.6-fold greater level of transcription in early development compared to adult levels (55). 
While posttranscriptional mechanisms seem to play the predominant role in increasing 
levels of specific B-tubulin isotypes during brain development (55), transcriptional 
regulation of the genes does occur in a developmentally specific manner. Any regulatory 
pathways that are found governing the expression of the tubulin genes during cardiac 
hypertrophy might give clues to more global mechanisms of gene regulation during 
growth andlor terminal differentiation. 
Because the B-tubulin genes are developmentally regulated by transcription, we 
hypothesized that, like other embryonically expressed genes such as ANF and a-MHC, 
the tubulin genes are transcriptionally regulated during hypertrophy. We tested this 
hypothesis by analysis of the levels and stability of the B-tubulin isotype mRNAs during 
hypertrophy. We found that the genes for BI and BII indeed were likely regulated 
transcriptionally during cardiac hypertrophy. However, other mechanisms of gene 
regulation must be occurring, because we consistently saw increases in BIV tubulin 
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mRNA levels while the protein did not appear to change. Other labs have shown that B-
tubulin mRNA can be degraded in an isotype-specific manner (56), so it is possible that a 
combination of transcriptional and post-transcriptional regulatory mechanisms are being 
used to control the levels of the specific B-tubulin isotypes during hypertrophy. It is also 
highly likely that these same regulatory mechanisms are controlling these genes during 
cardiac, and possibly, skeletal muscle development. 
Because of possible parallels between hypertrophic and developmental regulation, 
we explored cellular models of hypertrophy and development to use for promoter studies 
of the B-tubulin genes. One model of hypertrophy, phenylephrine-treated neonatal rat 
cardiocytes, showed small increases in total B-tubulin mRNA levels. However, no change 
was seen in the protein levels of either BI or BII tubulin in this model (data not shown). 
Additionally, other labs have shown that, clearly, increased B-tubulin message in this 
model is caused by increased message stability, not changes in regulation of transcription 
(57). Cellular models of skeletal muscle development, in particular the serum-starved 
C2C 12 cell line, do not display the same changes in B-tubulin isotype regulation that is 
seen in skeletal muscle tissue. This is probably due to the lack of homogeneity present in 
the population of cells on any given plate. Current studies in this lab are focused on 
finding a cell model that would allow for the study of the B-tubulin promoters in a way 
that would give insight into their hypertrophic and developmental regulation. 
High levels of expression of free B-tubulin protein in the context of increased 
levels of B-tubulin mRNA was a surprising finding, considering that normally B-tubulin 
mRNA stability is decreased by increasing levels of free tubulin (reviewed in (58». This 
observation afforded an opportunity to study another form of gene regulation in a 
terminally differentiated cardiocyte, specifically, the co-translational regulation of B-
tubulin message stability by the B-tubulin protein itself. Changes in levels of free tubulin 
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proteins occur most notably right before mitosis, when the interphase microtubules are 
depolymerized in preparation for the formation of the mitotic spindle. For this reason, it 
seems logical that a terminally differentiated cell might lose the ability to regulate its 
tubulin levels in this manner, since it no longer really needs it. When we first observed a 
difference in the way that dividing neonatal cardiocytes and non-di viding adult 
cardiocytes handled depolymerization of microtubules, we hypothesized that terminally 
differentiated cells indeed did lack this autoregulatory mechanism. However, we found 
that terminally differentiated cardiocytes were able to utilize this autoregulatory 
mechanism when they were treated with insulin. This finding can be interpreted in 
several different ways, given the complex signaling pathways that are activated by 
insulin. 
We originally designed the experiments on insulin-treated adult cardiocytes with 
the idea that the cells might not be down-regulating their B-tubulin rnRNA after exposure 
to colchicine because of low protein synthesis rates. In other words, because the 
autoregulatory downregulation of B-tubulin mRNA levels requires active protein 
synthesis, stimulation of protein synthesis might be needed in these cells to engage the 
autoregulatory mechanism. Insulin is known to stimulate protein synthesis in a number of 
different ways (reviewed in (59) and (60)). Specifically, insulin acts through the tyrosine 
kinase insulin receptor and insulin receptor substrate (IRS) proteins to activate several 
phosphatidylinositol 3-kinase (PI 3-kinase) and Ras-dependent pathways. Through PI 3-
kinase, the kinase mTOR (mammalian target of rapamycin) is activated, leading to the 
parallel phosphorylation of eukaryotic initiation factor-4E binding proteins (eIF-4EBPs 
or 4E-BPs) and the p70 ribosomal S6 protein kinase (reviewed in (59)). 4E-BPs inhibit 
protein translation initiation by competitive binding to eIF-4E, whose association with 
eIF-4G is important for the formation of the eIF-4F initiation complex (61). 
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Phosphorylation of these proteins leads to dissociation from eIF-4E and relieves this 
translational inhibition in many different cell types (reviewed in (59)). Insulin also 
stimulates translation initiation directly through phosphorylation and activation of eIF-4E 
(reviewed in (59)). Finally, insulin also stimulates translation initiation through activation 
of eIF-2B, a guanine nucleotide exchange factor for eIF2 (also reviewed in (59)). 
A simple interpretation of these experiments would be that stimulation of protein 
synthesis is indeed required for downregulation of B-tubulin mRNA levels in response to 
colchicine treatment of adult cardiocytes. However, insulin has a wide array of effects on 
the cell that are unrelated to protein synthesis. For instance, through the Ras/RaflMEK 
signal transduction pathway, insulin stimulates immediate early gene expressIon 
(reviewed in (60)). In addition, through PI 3-kinase, insulin activates the FKHR 
(ForKhead in Human Rhabdomyosarcoma) transcription factor family, which in tum 
stimulates the transcription of genes involved in apoptosis, glucose production, and entry 
into the cell cycle (reviewed in (62)). Finally, insulin also regulates cell morphology 
changes and glucose transport, mostly through PI 3-kinase dependent pathways, and 
often in ways that alter the actin cytoskeleton in L6 myotubes (reviewed in (60)). The 
exact mechanism of B-tubulin autoregulation of its own mRNA levels is unknown. 
Therefore, it is possible that there exists some co-factor required for this mechanism that 
is normally either not activated or physically unavailable at the site where it is needed in 
the adult cardiocyte. Insulin signaling might cause the activation or cytoskeletaI 
rearrangements needed to engage this cofactor that hypertrophic signaling does not 
provide. However, the end result of these experiments shows that the terminally 
differentiated cardiocyte is capable of utilizing the B-tubulin autoregulation pathway. 
So could there be another reason that during pressure overload-induced 
hypertrophy, there is concomitant increase in both message levels and free protein levels? 
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In particular, prevIous microinjection studies have shown that even increases in 
intracellular tubulin content of as little as 25%-50% normally invoke the autoregulatory 
mechanism (35). We propose that the most important factor in determining whether 
autoregulation of tuhulin message stability occurs might be the rate at which free tubulin 
heterodimers appear. In other words, cells are capable of withstanding a large increase in 
the levels of free tubulin protein as long as the increase is gradual. We can imagine that 
the cardiocyte, because of the combination of growth and stress stimuli it is receiving 
following pressure overload, changes its transcription patterns to one of a developing cell, 
complete with increases in levels of tubulin mRNA. This in tum leads to a gradual 
increase in the level of B-tubulin proteins, and eventually increased amounts of 
microtuhules. A sudden increase in tubulin protein levels, that occurs, for instance, after 
depolymerization of microtubules with colchicine, causes a decrease in tubulin mRNA 
stability, exactly as is seen after sudden depolymerization in mitotically active cells. This 
theory still allows that the autoregulatory mechanism' is in place to affect the amount of 
tubulin message translated after the rapid depolymerization of interphase microtubules. 
Determination of the factor or factors that are involved in mediating this effect remains 
an important task for cell biologists, as it hints at a highly novel mechanism for 
posttranscriptional regulation of message levels. 
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CHAPTER 3: OVEREXPRESSION OF THE BETA TUBULIN ISOTYPES 
INTRODUCTION 
This chapter focuses on the work that was done to explore whether changes in B-
tubulin isotype levels could directly cause changes in microtubule stability. Because 
mammalian Ct- and B-tubulin isotypes are so highly conserved across species and because 
they exhibit tissue- and development-specific expression, many have proposed that the 
isotypes have functional significance. Most of the data in the past, however, have 
suggested otherwise. For instance, when purified bovine brain tubulin, which includes the 
brain-specific BII and BIll isotypes, is injected into 3T3 fibroblasts, it co-assembles with 
endogenous tubulin into all the microtubules of the cell (63). More strikingly, when a 
hybrid chicken-yeast B-tubulin was made that contained the extremely divergent C-
terminus of a yeast B-tubulin, it co-assembled in 3T3 fibroblasts without alteration in 
microtubule function (64). There have been many similar studies in which tubulin 
isotypes are known to be interchangeable (65-69). 
However, there are cases, both in vitro and in vivo, where tubulin isotypic makeup 
does have an affect on microtubule function and/or stability (reviewed in (22, 70, 71)). 
For instance, studies in Elizabeth Raffs lab (72) showed that, in Drosophila, expression 
of different tubulin isotypes does have an effect on microtubule structure and function. If 
the Drosophila 83 tubulin is expressed in male germ cell lines in place of the testis-
specific B2, axoneme formation and meiotic spindle formation are blocked. If 82 and B3 
are co-expressed in male genn-line cells, the males become sterile and have an abnormal 
morphology of the outer doublet microtubules of the axoneme. This only occurs if the B3 
levels are at greater than 20% of the total tubulin population. 
Studies in the lab of Richard Luduefia have focused on the question of whether or 
not the B-tubulin isotypes have intrinsic differences in their assembly kinetics. 
Immunoaffinity chromatography was used to isolate isotypically pure aBII, aBIII, and 
aBIVa tubulin heterodimers from bovine brain (73). The purified dimers all assembled 
more rapidly in vitro than a mixed population of heterodimers{73, 74). More specifically, 
in the presence of tau or MAP 2, the aBII and aBIII heterodimers assemble more readily 
than aBIV (73). Moreover, microtubules made up of aBIII heterodimers are more 
dynamic than microtubules made up of aBII, aBIV, or mixed populations of heterodimers 
(75). Remarkably, mixing the aBIII heterodimers with increasing amounts of aBII could 
modulate this dynamic behavior. At a ratio of 20% BIll 80% BIll, the microtubules 
behaved as did pure BIll microtubules, but at a ratio of 50%1 50%, the microtubules 
behaved more like BII microtubules (75). 
Obviously, the presence of MAPs and other regulators of microtubule stability in 
vivo might alter any affect of intrinsic differences in B-tubulin isotypes on the kinetics of 
microtubule assembly. There is, however, evidence that the isotypes might confer 
differing stabilities on microtubules in the cell. In particular, several studies have shown 
differences in isotype make-up for populations of stable microtubules. In neuronal PI9 
cells that are induced to differentiate, there is selective sorting of BII tubulin into 
colchicine-stable microtubules (76). In this lab, we have data that show that BI tubulin 
selectively sorts into cold-stable microtubules in the heart during pressure overload-
induced hypertrophy (24). Some of the most extensive correlative studies that have been 
made are the ones that explore changes in B-tubulin isotype expression in drug-resistant 
cell lines. 
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Cells can acquire resistance to microtubule poisons in several ways (reviewed in 
(77)). Studies in Fernando Cabral's laboratory at the University of Texas Medical School, 
Houston, TX, have reported a way in which eRO cells can acquire resistance to Taxol by 
altering their B-tubulin to affect microtubule stability (77, 78). Taxol is a drug that acts to 
disrupt microtubule dynamics by stabilizing microtubules. Therefore, these mutations in 
the B-tubulin molecule affect microtubule kinetics is such a way as to decrease 
microtubule stability, thereby counteracting the effects of the drug (79). Studies in other 
labs have also implicated increased expression of certain isotypes of B-tubulin for causing 
the resistance found in many tumor cell lines to Taxol and other microtubule poisons. 
These have included reports of increased BII tubulin in a Taxol-resistant murine cell line 
(80); reports of increased expression of BI, BII, BIll, and SIVa in the drug-resistant A549 
human lung cancer cell line and increased expression of BI, BIll, and BIVa in Taxol-
resistant human ovarian tumors (81); studies in K562 human leukemia cells that have 
implicated BIVa-tubulin in Taxol resistance (82); and studies in DU-145 human prostate 
carcinoma cells that have revealed an increase in BIll and BIVa-tubulin expression in 
association with resistance to estramustine, another drug that affects microtubule 
assembly (83). 
While these studies show a correlation of certain B-tubulin isotypes with stable 
populations of microtubules, they do not directly prove a cause and effect relationship. In 
light of the fact that previous studies have mostly supported the idea that the different 
isotypes do not affect microtubules, direct experimentation is needed to prove anything 
more than a simple correlation. In our studies of pressure overloaded RV tissue, we 
established that there is an increased stability of microtubules concomitant with an 
increased level of expression of the BI and Bll-tubulin isotypes. Because the BII isotype 
makes up only 5% of the B-tubulin protein expressed after induction by pressure 
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overload-induced hypertrophy (24), we did not feel that it could make an appreciable 
difference in microtubule stability. For this reason, we focused our attention on the BI 
isotype and its effect on microtubule stability. In collaboration with Fernando Cabral, we 
have studied the effect of stable transfection and overexpression of the BI-tubulin isotype 
in Chinese hamster ovary (CHO) cells. By adenoviral infection, we have also studied the 
effect of overexpression of the BI tubulin isotype in the adult cardiocyte. We felt that it 
was important to study the effects of BI expression in this system compared to the effects 
in cardiocytes, because a discrepancy seemed to exist between our data and data 
generated in other labs as to the possible consequences of BI-tubulin expression. 
Specifically, we have shown increased expression of BI in the presence of hyperstable 
microtubules, and even shown sorting of BI into cold-stable microtubules (24). Other 
labs, however, have shown increased expression of BI in mitotically active cells that are 
resistant to Taxol, a microtubule-stabilizing drug. In the previously mentioned studies in 
F. Cabral's lab, it has been well established that cells with resistance to Taxol due to B-
tubulin mutations have hypostable microtubules. Presumably, changes in isotype 
expression, if they were indeed causative of drug resistance, would also lead to decreased 
stability of the microtubules. 
We felt that it was possible that BI-tubulin overexpression would lead to altered 
stability of microtubules primarily because of increased affinity for MAPs. Therefore, 
there might be cell-specific modulation of the response to BI -tubulin overexpression 
based on what factors are present in the cell's milieu. In addition, it seemed likely that 
cells that are resistant to certain drugs have many changes in their phenotype other than 
just B-tubulin composition, due to the way they are selected. To further elucidate effects 
of BI overexpression in different systems, we asked the following questions: does 
overexpression of BI or other tubulins in CHO cells directly cause increased resistance to 
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Taxol and does overexpreSSIon of BI tubulin In the adult cardiocyte directly cause 
increased microtubule stability? 
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METHODS 
Construction of j3-tubulin isotype-speciJic overexpression vectors. CHO CBI is a 
previously described class I B-tubulin cDNA (84, 85). It was modified to express a 9 
amino acid hemaglutinin (HA) tag at the C-terminus (86). Mouse class II and IVb B-
tubulin cDNAs (47) were originally named MB2 and MB3 and were kindly provided by 
Nicholas Cowan at New York University, NY, NY. To obtain regulated expression, 
pcDNA3 (Invitrogen, Carlsbad, CA) was modified to incorporate the features of a 
tetracycline regulated vector system and the new plasmid was named pTOPneo; this 
vector contains a minimal cytomegalovirus (CMV) promoter downstream from 7 copies 
of the tetO operator sequence for tetracycline regulated expression (87). A 1.5 kb Hind 
IIIINot I fragment from plasmid BlskHABI (86) containing the entire HABI-tubulin 
coding sequence was cloned into the unique Hind 1111 Not I sites of pTOPneo to create 
pTOPneo-HABI. This vector conveniently contains, upstream of the HA tag, a blunt-end 
Eco47 III restriction site. The BII and BIVb cDNAs were then cloned into the same vector 
in place of the BI eDNA in-frame with the HA tag as follows. PCR was used to amplify 
the cDNAs provided by N. Cowan using primers that inserted a 5' Hind III site and left a 
blunt 3' end. This was accomplished using Pfu polymerase (Stratagene), which does not 
leave a single A overhang. The PCR products were then gel-purified, cleaned using the 
Qiaquick Gel Purification kit (Qiagen, Valencia, CA), and ligated into the Hind 1111 
Eco47 III digested pTOPneo-HABI vector. The full length of the coding region for each 
construct was then sequenced to ensure that no errors were introduced during the PCR 
amplification. The B-tubulin isotype-specific cDNAs were now under the control of a tet-
regulated CMV promoter; in addition, this vector contained a G418 resistance gene to 
allow for selection of stable transfectants. 
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Construction of the pTOPpuro-tTA vector. A plasmid carrying the coding sequence of the 
tetracycline-regulated transactivator (tTA) was made by first replacing the neomycin 
resistance gene of pTOPneo with the puromycin resistance gene from the vector pPUR 
(Clontech, Palo Alto, CA), to create pTOPpuro. The sequence for tT A was then added by 
cloning a 1 kb Eco RII Bam HI fragment from the plasmid pUHD 15-1 (87) into 
pTOPpuro to create pTOPpuro-tT A. This plasmid was transfected into eHO cells to 
create the CHO cell line tT Apuro 6.6. 
Transfection, selection, and maintenance of CHO cell lines. The growth medium for all 
cells was alpha modification of minimum essential medium (aMEM) containing 5% fetal 
bovine serum, 50 U/ml penicillin, and 50 Jlg/ml streptomycin (all from Gibco BRL). 
Plasmid DNA was prepared using the QIAfilter Plasmid Maxi Kit (Qiagen) according to 
the manufacturer's instructions, and used to transfect CHO strain tT Apuro 6.6a. 
Transfections were carried out using 1 Jlg of plasmid DNA (0.2 Jlg in the case of 
HABIL228P) and Lipofectamine (Gibco BRL) according to the manufacturer's instructions, 
except that the growth medium contained 1 Jlglml tetracycline (Sigma, St. Louis, MO) to 
prevent expression of the transfected DNA until time of analysis. Stable transfected cell 
populations were selected and maintained at 37° C, 5% C02 in growth medium that 
contained 1 Jlglml tetracycline and 2 mg/ml G418 (Gibco BRL). 
Selection of Taxol-resistant cells. To determine whether expression of specific B-tubulin 
isotypes could confer Taxol resistance, CHO strain tT Apuro 6.6a was transfected with 
each of the HA tagged cDNAs in parallel. Cells from each transfection were then 
trypsinized and reseeded in duplicate into 6-well dishes containing normal growth 
medium with tetracycline (5-10 X 102 cells), medium with G418 plus tetracycline (5-10 
X 104 cells), or medium with 0.2 Jlglml Taxol and no tetracycline (5-10 X 1(f cells). The 
dishes were incubated at 37° C for 7 days until colonies appeared. Wells that failed to 
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produce any visible colonies were incubated an additional week and scanned 
microscopically to be certain we would not miss any slow growing colonies. Cells from 
one set of duplicate wells were trypsinized and used for propagating the culture for 
further testing, and cells in the second set of wells were stained with methylene blue as 
previously described (88) to count the number of resistant colonies. 
In addition to their direct selection, selections for Taxol-resistant cells were also 
carried out on cell populations that had previously been selected in G418 and were 
therefore enriched for cells expressing the transfected B-tubulin. In this case the cells 
selected in G418 plus tetracycline were trypsinized and reseeded in duplicate into 6-well 
dishes at high (4-5 X 103) and low (150-200) cell density in normal medium without 
tetracycline for 6 hours to allow induction of transgene expression. Prior studies indicate 
that 3 hours is the earliest time that significant production of the transfected tubulin can 
be detected (F. Cabral, unpublished data). Following the 6-hour induction, one set of 
duplicate wells was changed to medium containing 0.2 J.tglml Taxol while the other set of 
wells remained in normal medium without tetracycline. 
Western blotting of CHO cell extracts. To measure the relative accumulation of 
transfected versus endogenous B-tubulin, transfected cell populations that had undergone 
selection were seeded into 24-well dishes in the continued presence or absence of 
tetracycline and incubated overnight (-20 hours) at 37°C. The medium was aspirated, the 
cells were washed 2 times with phosphate buffered saline (PBS, Gibco BRL), and the 
cells were then lysed by the addition of 100 J.tl of hot (100°C) sodium dodecyl sulfate 
(SDS) sample buffer (89). Protein and DNA in the lysate were precipitated by the 
addition of 5 volumes of cold (4°C) acetoneINH40H (20/1), the DNA was fished out with 
a thin gauge needle, and the protein was centrifuged at 12,000 g for 5 minutes. 
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The pellet was redissolved in 30 III of SDS sample buffer and 5-15 III were run on 
a 7.5% polyacrylamide SDS minigel (Bio-Rad Laboratories, Hercules, CA). Proteins 
were electrophoretic ally transferred onto a nitrocelleulose membrane and probed with a 
mixture of mouse monoclonal antibodies to B-tubulin (Tub 2.1, 1 :2000 dilution, Sigma) 
and actin (C4, 1 :5000 dilution, ICN Biomedicals, Costa Mesa, CA). This was followed 
by incubation in peroxidase-conjugated goat antimouse IgG (1 :2000 dilution, Cappel 
Laboratories, Cochranville, P A) and detection by chemiluminescence (Kirkegaard & 
Perry Laboratories, Gaithersburg, MD) using the manufacturer's instructions. 
Immunofluorescence of CHO cells. Cells were grown on glass covers lips to 
approximately 70% of confluence and fixed in methanol (_20 0 C) for at least 10 min as 
previously described (86). The primary antibody used was mouse monoclonal 12CA5 
(Boehringer Mannheim Corp., Indianapolis, IN), specific for the HA tag. This was 
followed by fluorescein-conjugated goat antimouse IgG (Cappel Laboratories). 
Photographs were taken on TMAX 400 film (Eastman Kodak, Rochester, NY) using an 
Optiphot microscope equipped with epifluorescence and a 40X fluor objective (Nikon 
Inc., Melville, NY). 
The pAd.CMV-LINK system for construction of recombinant adenovirus. We used the 
system developed by Chartier et. al. (90) to construct adenoviruses for use in the 
infection of adult feline cardiocytes. This system employs recombination of a vector that 
contains most of the adenovirus genome with a shuttle vector that has a CMV promoter 
upstream of the E3 region as well as a multicloning site and SV40 polyadenylation signal 
in place of the El region. The shuttle vector recombines in bacteria through homology in 
the 0-1 map unit and 9-16 map unit regions. The resulting recombinant adenovirus 
contains most of the DNA for the Ad 5 serotype adenovirus, minus the El region, which 
is replaced by the cloned gene along with a poly A sequence. Both the parent adenovirus 
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genomic vector and the shuttle vector contain sequences that allow them to be propagated 
in bacterial culture supplemented with ampicillin. Therefore both are linearized before 
recombination to prevent contamination of non-recombined ampicillin-resistant colonies. 
Mutagenesis of HA-tagged j3IV eDNA to remove an internal Nar I site. Because 
recombination with adenoviral DNA required linearization of the pAd construct with Nar 
I and Nhe I, we needed to remove any Nar I or Nhe I sites in the tubulin cDNAs before 
cloning them into the pAd.CMV-LINK.l shuttle vector. There was only one such site, a 
Nar I, at nucleotide number 49 of the SIV cDNA coding sequence. We used PCR primers 
to mutate the C at nucleotide number 51 to a T in order to remove this sequence without 
affecting the amino acid sequence. Mutagenesis was carried out using the Quickchange 
Site Directed Mutagenesis kit from Stratagene. 
peR of cDNA for cloning into pAD. CMV-LINK. 1 shuttle vector. HA-tagged SI and SIV 
tubulin cDNAs were amplified using Pfu polymerase (Stratagene). Briefly, the pTOPneo-
HASI and pTOPneo-HASIV vectors were amplified with 500 nM each of PCR primers 
that inserted an upstream blunt end and a downstream Hind III site. The reactions 
included 200 JIM of each dNTP, about 200 ng of template DNA, 2.0 units of Pfu 
Polymerase, and Ix Pfu polymerase buffer. The reactions were cycled Ix 45 seconds at 
94°C; 25x 45 seconds at 94°C, 45 seconds at 65°C, and 2.5 minutes at 72°C; and Ix 10 
minutes at 72°C. The products, by virtue of the primer sequences, had a 5' blunt end in 
the 5' UTR of each cDNA and a 3' Hind III site just past the stop codon following the 
HA tag. The products were ethanol-precipitated, resuspended in a small volume of 
ddH20, and electrophoresed on a 1% agarose gel. The 1.2 kb products were then cut out 
of the gel with a scalpel, and the DNA was isolated with the Qiaquick Gel Extraction kit 
from Qiagen. The products were then digested with 5 units of Hind III at 37°C overnight. 
The digested DNAs were purified using the Qiaquick PCR Purification Kit (Qiagen) and 
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ligated into an Eco RV/Hind III-digested pAd.CMV-LINK.l vector. The clones were 
transformed into E. coli DH5a cells, colonies were picked, and clones were screened for 
the correct sequence throughout the entire coding region to ensure that no unwanted 
mutations were introduced during PCR amplification. To verify that the CMV promoter 
constructs were capable of overexpression in the 293 kidney cell line, 4 Jlg of each DNA 
was transfected into an 80% confluent 60 mm plate of cells using Lipofectamine (Gibco 
BRL), according to manufacturer's protocol. After 48 hours in 10% fetal bovine serum, 
the cells were scraped into 1 x SDS loading buffer (89) to isolate total protein. Equal 
amounts were then loaded onto 7% Tris-acetate gels (Novex), along with extract from 
non-transfected 293 cells, and Western blotting was performed with an anti-HA 
polyclonal antibody (Zymed, San Francisco, CA, USA), at a 1: 2000 dilution. 
Recombination of the shuttle vector with adenoviral DNA. The viral DNA vector 
pTG3602 was recombined with the pAd shuttle vector constructs in the E. coli strain 
BJ5183. Briefly, 200 JlI of competent cells were transformed with 50 ng of CIa I 
linearized pTG3602 and 2 Jlg of the Nar I/Nhe I fragment from the pAdCMV/HABI and 
BIV vectors. Colonies were screened for positive recombinants by restriction digestion 
with Xho I and southern blotting using probes specific for the coding regions of the B-
tubulins. Positive clones were then transformed into E. coli DH5a cells, and large-scale 
DNA isolations were done with each clone (Qiagen). This DNA was then used to 
manufacture adenovirus by transfection into 293 cells. 
Production of adenovirus. Approximately 2 JLg of Pac I digested B-tubulinladenoviral 
DNA recombinant was transfected into 50% confluent 293 cell cultures in 60-mm plates 
using Lipofectamine. The cells were fed every 2 days until plaques started to form (7-10 
days post-transfection). When the cells were almost completely lysed (approximately 12 
days post-transfection), they were scraped into their media and taken through 3 freeze-
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thaw cycles in liquid nitrogen. The cell debris was then centrifuged for 5 min. at 900g 
and some of the supematent was added to 100% confluent cultures of 293 cells on 60-
mm dishes. Protein was isolated after 1 day to check for expression of HA-tagged B-
tubulin by Western blot. The remaining supernatent was used to overlay confluent 293 
cells for plaque purification. After a 4-hour incubation with 1-3 rol of viral supernatent, 
the cells were overlaid with 0.5% agaroselDMEM. After about 7 days, individual plaques 
were picked and used to infect 60-mm dishes of confluent 293 cells. When the cells were 
lysed, the overlying media was used to infect a lS0-mm dish of confluent 293 cells. 
Again, after lysis, the media was used to infect 15-20 150-mm dishes for a large-scale 
adenoviral preparation. The cells were scraped after 1 day (when they began to show 
cytotoxicity, but had not yet lysed) into 5 ml PBS per dish, and the cells were centrifuged 
and resuspended in 10 ml total PBS. The cells were then taken through several freeze-
thaw cycles. The cell debris was centrifuged at 900 g for 5 min., and the supematent was 
put onto a CsCI gradient as follows: 500 p,l of 1.5 glml CsC!, 3 ml 1.35 g/ml CsCI, 3 ml 
1.25 glml CsC}, and 5 ml viral lysate. The tubes were spun in an ultracentrifuge at 35,000 
RPM for 2 hours at 4°C with no brake. The white adenoviral band was withdrawn and 
dialysed overnight against PBS with 10% glycerol. The virus was then aliquotted and 
stored in liquid nitrogen. 
Adenoviral infection offeline adult cardiocytes. Adult feline cardiocytes were isolated as 
in chapter 2. The cells were plated on laminin-coated coverslips at a density of 3.1 X 104 
cellsl cm2 or on laminin-coated cell culture dishes at a density of 1.9 X 105 cellsl cm2 in 
M199 media with antibiotics. After 18-24 hours, the cells were placed in Piper's media (5 
mM creatine, 5 mM taurine, 2 mM camitine, 100 p,M ascorbate, 0.25 mM phenylalanine, 
0.2% bovine serum albumin, 10 JlM AraC, O.lJlM insulin, and 100 IVlml Penicillin-
Streptomycin in M199 medium) with differing amounts of adenovirus. After 18-24 hours, 
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the medium was changed to Piper's without adenovirus. The cells were then cultured for 
different times, depending on the experiment. 
Western blotting of protein isolated from infected cells. Protein was isolated from adult 
feline cardiocytes and 293 cells using I % SDS lysis buffer as described in chapter 2. 
Equal amounts of protein were then loaded onto a 7% tris-acetate gel (Novex). After 
transfer to PVDF membrane the blots were probed either with an antibody to B-tubulin, 
as described in chapter 2, or a polyclonal rabbit antibody to the HA tag as described 
above. In one experiment, the proteins from infected adult cardiocytes were probed with 
the antibodies to the tyr-, glu-, and d2-tubulin proteins at a concentration of I: 10,000, 
I :2000, and I: 10,000, respectively (10). 
Immunofluorescence of adult feline cardiocytes. Cells plated on glass coverslips were 
extracted in I % Triton X-IOO in microtubule stabilization buffer, washed 3 times in the 
same buffer, and fixed in 3.7% formaldehyde as described in (10). For double-labeling of 
the HA tag and a-tubulin, the coverslips were blocked in 10% donkey serum in 0.1 M 
glycine/ PBS, and incubated overnight at 4°C with 1: 100 dilution of monoclonal HA 
antibody (12CA5, Boehringer Mannheim, Indianapolis, IN) and I :50 dilution of an a-
tubulin antibody (YLI/2, Harlan, Indianapolis, IN). The cells were then washed 3X in 
PBS and incubated 2 hours at room temperature with FITC-conjugated anti-mouse IgG 
and Cy3-conjugated anti-rat IgG (Jackson ImmunoResearch Laboratories, West Grove, 
PA). The cells were then washed 3X in PBS and mounted on glass microscope slides in a 
glycerol mounting solution (Molecular Probes, Eugene, OR). For double-labeling of the 
HA tag and post-translationally modified a-tubulin molecules, the primary antibodies 
were the HA antibody (Boehringer Mannheim, 1:100) and a 1:50 dilution of either the 
tyr-, glu-, or d2-tubulin antibodies (10); the secondary antibody for the et-tubulin staining 
was a Cy3-conjugated anti-rabbit IgG (Jackson). For double-labeling of the HA and Myc 
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tags, a 1:100 dilution of a polyclonal anti-myc antibody (Upstate Biotechnology, Lake 
Placid, NY) and a Cy3-conjugated anti-rabbit secondary (Jackson) were used. For some 
of the experiments, double-labeling of the HA tag and unmodified a-tubulin protein was 
achieved by using the same primary antibodies mentioned above, but using an FITC-
conjugated anti-rat IgG and a Cy3-conjugated anti-mouse IgG. Confocal micrographs 
were then made using an Olympus Fluoview Confocal Microscope (Olympus Optical 
Co., Ltd., Tokyo, Japan). 
Nocodazole treatment of adult cardiocytes. Before fixation and immunofluorescence, the 
cells were treated for 0, 1, 1.5, or 2 hours in 0.3, 3.0, or 30 J.tM nocodazole in M199 
medium. The extraction procedure was then carried out in the continual presence of the 
same concentration of nocodazole. 
Cold-stability of microtubules In adult cardiocytes. Before fixation and 
immunofluorescence, the cells were treated for 0, 0.5, 1, 1.5, or 2.0 hours at 4°C, 6°C, or 
goC in 25mM Hepes buffered M199. The extraction procedure was then carried out with 
ice-cold buffers, except for the untreated control cells. 
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RESULTS 
Because growth of mitotically active cells is often inhibited by changes in the 
microtubular cytoskeleton, we wanted to ensure that initial transfections in CHO cells 
were carried out in the absence of exogenous gene overexpression. For this reason, we 
cloned the B-tubulin isotypes into a vector whose expression was controlled. We used a 
tetracycline-regulated vector originally described by Gossen and Bujard (87) that 
contains a CMV promoter downstream of seven copies of the tetO operator from E. coli. 
The constructs then were transfected into a CHO cell line, tT Apuro6.6a, that expresses 
the tetracycline regulated transactivator (tTA) under tetracycline control (91). The tTA 
transacti vator is a fusion protein composed of the wild-type tetracycline repressor protein 
from E. coli (TetR) and the VP16 activation domain (AD) of herpes simplex virus. The 
fusion protein is regulated by tetracycline so that it only binds to the tetO operator when 
tetracycline is absent, allowing the VP16 AD to activate the CMV promoter. Therefore, 
in this system, the gene of interest is only expressed in the absence of tetracycline or its 
derivatives. The vector also contained a G418 resistance gene so that stable transfectants 
could be selected. 
Almost all of the B-tubulin isotypes, including BI, BII, BIll, and BIVa, have been 
reported to be increased in drug-resistant cells. To find out if changes in B-tubulin isotype 
expression actually can cause drug resistance, or if they are correlative, we expressed the 
BI, BII, and BIVb isotypes in CHO cells. CHO cells normally express the BI, BIVb, and 
BV isotypes in a 70:25:5 ratio (92). This afforded an opportunity to explore not only the 
ability of different isotypes to confer drug resistance, but also the opportunity to examine 
whether normally non-expressed isotypes are stable when overexpressed. For this, we 
determined if the exogenous B-tubulin proteins were incorporated into microtubules after 
transfection of CHO cells. The cDNAs were fused to an HA epitope tag to allow for easy 
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detection of the exogenously expressed gene. Transient transfections were carried out and 
the cells were stained with an antibody to the HA tag. Figure 3-1 shows cells that were 
transiently transfected with the HASI, HABII, and HABIVb, constructs, as well as a 
construct containing a mutant BI tubulin that has a leucine to phenylalanine substitution at 
residue 228; this construct is known to cause resistance to Taxol when overexpressed in 
CHO cells (93). After removal of tetracycline from the media to allow expression of the 
cDNAs, antibodies to the HA tag detected proteins throughout the microtubule network, 
indicating that all of the constructs were expressing functional proteins that could 
assemble into microtubules. 
Next, transfections were carried out to determine if overexpression of specific 
isotypes could confer Taxol resistance. For this, several different selective conditions 
were used. One group of cells was exposed to medium with tetracycline. These 
nonselective conditions should allow all cells to grow regardless of whether they do or do 
not express the tranfected eDNA. Tetracycline was included to suppress transfected HAB-
tubulin expression and circumvent the possibility that the overexpressed protein might 
prove toxic to cell survival. This control group was used as the baseline to calculate 
transfection efficiencies. A second group of cells received medium containing 0418 plus 
tetracycline. The 0418 was expected to select cells that were stably transfected and 
expressed the neomycin resistance gene in the plasmid. Tetracycline was again included 
to eliminate any possible toxicity from overexpression of HAB-tubulin. These conditions 
should select the total stably transfected cell population. A final group of cells received 
medium containing Taxol but no tetracycline. The expectation was that removal of 
tetracycline would allow expression of the transfected HAB-tubulin, while inclusion of 
Taxol would determine whether the HAB-tubulin could confer Taxol resistance. The 
results of this experiment are summarized in Table 3-1. All the transfections produced 
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Figure 3-1. The HAJ3-tubulin proteins are incorporated into the CHO cell microtubular network. Cells 
from CHO strain tTApuro 6.6a were seeded onto glass coverslips and transfected with HAJ3
J 
(A), 
HA~II(B), HAJ3IVb (C), or HAJ3J(L228F) (D) cDNA. At 24 hours posttransfection, the cells were extracted 
with a microtubule stabilizing buffer, fixed, and stained with an antibody specific to the HA tag. Ar-
rows indicate the positions of cells expressing the transfected HAJ3-tubulin. Bar, 10J.!m. 
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Table 3-1. Selection of transfected cells for resistance to G418 and to Taxol 
HAJJI HAjJII HAjJIVb HAjJIL228F 
aMEM+tet 62400 70200 63700 81400 
(1) (1) (1) (1) 
G418 + tet 242 298 240 80 
(3.9 X 10-3) (4.2 X 10-3) (3.8 X 10-3) (1 X 10-3) 
TX 0 0 0 9 
«1.6 X 10-5) «1.4 X 10-5) «1.6 X 10-5) (1 X 10-4) 
Cells transfected with various HAB-tubulin cDNAs were seeded onto tissue culture 
dishes containing no selective drug (aMEM + 1 J-tg/ml tetracycline), 2 mg/ml G418 + 1 
~g/ml tetracycline, or 0.2 J-tg/ml Taxol (TX). For each selection, the number of surviving 
colonies is shown along with the cloning efficiency in parentheses. The cloning 
efficiency in aMEM + tetracycline was arbitrarily set at 1 for each transfected cell line. 
Note that the number of colonies in aMEM + tetracycline was multiplied by 100 because 

















Cells transfected with the various HAB-tubulin cDNAs were first selected in G418 + 
tetracycline and were then replated under non-selective conditions (aMEM) or in 0.2 
J'f 




Figure 3-2. Production of HA~-tubulin in transfected cells. Cells transfected with the indicated HA~­
tubulin cDNAs and selected in G418 were run on SDS polyacrylamide gels, electroblotted onto nitro-
cellulose, and probed with antibodies to ~-tubulin and actin. Lanes marked with a '+' represent cells 
grown continuously in 1 J.lg/ml tetracycline and lanes marked with a '-' represent cells induced over-
night (20 hours) without tetracycline. The relative positions oftransfected HA~-tubulin (HA~), endog-
enous ~-tubulin (~), and actin are indicated in B. Also in B, the left 2 lanes represent cells transfected 
with HA~I(L228F) and selected in G418 while the right 2 lanes represent the same transfected cells se-
lected in 0.2 J.lg/ml paclitaxel. The left 2 lanes were exposed longer to reveal the minor production of 
the transfected HA~I(L228F)-tubulin in the G418 selected cell population. Note that the transfected tubu-
lin is dramatically increased in the cells selected in paclitaxel. 
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We next directly tested the hypothesis that overexpression of the BI tubulin 
isotype can lead to increased microtubule stability in the terminally differentiated adult 
cardiocyte. For this, we constructed recombinant adenoviruses that allow for the infection 
of cardiocytes cultured on laminin-coated substrate. Once the recombinant adenoviruses 
had been constructed, we optimized the multiplicity of infection and kinetics of 
expression to achieve the highest level of expression. We then studied cardiocytes for 
changes in microtubule stability after overexpression of specific B-tubulin isotypes. 
Construction of the BI and SIV adenoviruses is described in detail in the methods 
section. We used a simplified system for viral construction that includes recombination in 
bacteria to make the replication-incompetent adenoviral genome with a cloned cDNA 
downstream of a CMV promoter (90). The pTOPneoHASI and pTOPneoHABIV vectors 
were used as PCR templates to generate the restriction sites needed to clone the HABI 
and HABIV cDNAs into the adenoviral shuttle vector. Once recombination with the 
engineered shuttle vector was done, we propagated the virus in the human kidney cell 
line HEK 293, which provides the missing El region of the adenoviral genome in trans 
(94). Single plaques were selected and amplified for the large-scale isolation of the 
adenoviruses. 
To determine if expression of the BI isotype could confer increased microtubule 
stability, the goal was to infect cardiocytes with high enough titers of adenovirus for long 
enough time to achieve replacement of the endogenous B-tubulin with the exogenous B-
tubulin. The first step was to determine the optimum multiplicity of infection (MOl) for 
each viral construct. Cells were plated on laminin-coated culture dishes and treated with 
increasing numbers of plaque-forming units (PFU). Cells were exposed to virus for 18 
hours and were lysed 4-5 days post-infection. Total protein was run on a SDS-PAGE and 
Western blots were performed with the polyclonal anti-HA antibody. Figure 3-3 shows 
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HA~I 
HA~IV 
Figure 3-3. Multiplicity of infection for HA~-tubulin adenoviruses. Plated cardiocytes were treated for 
18 hours with no virus or one of the HA~-tubulin viruses at increasing multiplicity of infection (MOl). 
Total protein was isolated 4 days after the start of infection and Western blots were performed with the 
HA tag antibody. The amount of exogenous tubulin produced peaks at about an MOl of 2000 for both 
viral constructs. 
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Figure 3-3. Multiplicity of infection for HA~-tubulin adenoviruses. Plated cardiocytes were treated for 
18 hours with no vi.rus or one of the HA~-tubulin viruses at increasing multiplicity of infection (MOl). 
Total protein was isolated 4 days after the start of infection and Western blots were performed with the 
HA tag antibody. The amount of exogenous tubulin produced peaks at about an MOl of 2000 for both 
viral constructs. 
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that the ideal MOl for each of the B-tubulin adenoviral constructs is about 2000 PFU/cell. 
The amount of expressed HA-tagged tubulin levels off at this Mal, and after this point 
there seems to be an increase in the level of higher and lower molecular weight bands that 
are detected by the HA antibody (data not shown). It is possible that as the level of 
expression increases more of the B-tubulin protein is being degraded or collecting into 
large complexes that are assembly-incompetent. For most of the remaining studies, an 
MOl of at least 1000 was used. 
The next step was to determine at what point post-infection exogenous protein 
levels were highest. Again, cells were plated on laminin-coated dishes and treated with 
adenovirus for about 18 hours. Cells were scraped at day 1 through day 5 post-infection 
and equal amounts of total protein were run on SDS-PAGE. Western blots were done 
with both the anti-HA antibody as well as the antibody for common B-tubulin. Figure 3-4 
shows the results of Western blots of cellular extracts from HABI and HABIV infected 
cardiocytes. The level of expressed protein peaks at about 3-4 days post-infection. Note 
that the HA-tagged tubulin proteins have a slightly slower electrophoretic mobility, 
allowing us to see that the level of endogenous B-tubulin at this MOl has been greatly 
reduced, if not completely replaced by the exogenously expressed protein. 
Immunofluorescence confocal microscopy was used to confirm that the expressed 
B-tubulin proteins were being incorporated into the microtubules of the cardiocytes. Cells 
were plated on laminin-coated glass coverslips and infected for 18 hours with a control 
RSV promoter virus that contained no insert, HABI expressing adenovirus, or HABIV 
expressing adenovirus at MOls of about 5000. After 2-3 days, the cells were fixed and 
stained with a mouse monoclonal anti-HA antibody and a rat monoclonal anti-a-tubulin 
antibody. The time course was shortened from the ideal 4-5 days because cells at this 
time point were better able to survive the extraction and fixation procedure. Cells were 
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Figure 3-4. Time course for HA~-tubulin adenoviral infection. Plated cardiocytes were treated for 18 
hours with one of the HA~-tubulin viruses at an MOl of 2000. Total protein was isolated at the time of 
infection and every day for 5 days post-infection, and Western blots were performed with a monoclonal 
~-tubulin antibody and a polyclonal HA tag antibody. For both adenoviral constructs, expression peaked 
around 4-5 days. 
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then stained with Cy3-conjugated anti-mouse and FITC-conjugated anti-rat secondary 
antibodies and observed by confocal microscopy. Figure 3-5 shows that both HA-tagged 
proteins are homogenously incorporated into essentially all of the microtubules of the 
cells. About 70-80% of the cells was infected with the HAB-tubulins. 
Once we had established that both adenoviral constructs were expressing high 
levels of protein in adult cardiocytes, we were able to start qualitatively measuring 
changes in microtubule stability in cells overexpressing specific S-tubulin isotypes. For a 
preliminary experiment, we used Western blots to check levels of post-translationally 
modified a-tubulins in infected versus non-infected cardiocytes. There are three different 
forms of a-tubulin that are known to indicate microtubule age: the tyr form, or the non-
modified a-tubulin that has a carboxy-terminal tyrosine residue; the glu form, which has 
been modified by the removal of the terminal tyrosine, leaving a carboxy-terminal 
glutamate residue (95-99); and the ~2 form, which has been modified by the further 
removal of the terminal glutamate (100-102). The presence of the last two forms indicates 
older, and therefore more stable, microtubules. Extracts from cells infected with HASI 
and HASIV for 3 days in the aforementioned time course experiments were compared 
with extracts from uninfected cells scraped on the same day from the same cell 
preparation. Equal amounts of protein were loaded on SDS-PAGE, and Western blots 
were performed with polyclonal antibodies to unmodified a-tubulin (Tyr-tubulin), de-
tyrosinated a-tubulin (Glu-tubulin), and de-tyrosinatedlde-glutamylated a-tubulin (~2-
tubulin) (10). Figure 3-6 shows that, while the Western blot with the B-tubulin antibody 
clearly indicates an almost total replacement of the endogenous B-tubulin with either the 
HABI- or HABIV- tubulin, there are no great changes in the levels of post-translationally 
modified a-tubulin proteins. This gives preliminary indication that the overexpression of 
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Figure 3-5. The HAS-tubulin proteins are incorporated into the microtubules of the adult 
cardiocyte. Cardiocytes were plated on laminin-coated coverslips and infected for 18 
hours with either control adenoviruses containing an RSV promoter with no insert (top 2 
panels) or the HASl (middle 2 panels) or HASIV (bottom 2 panels) adenoviruses at an 
MOl of about 5000. After 3 days the cells were fixed and stained for 
immunofluorescence with antibodies to the HA tag (panels on left) and a-tubulin (panels 
on right). The HAS-tubulin constructs appear to be homogeneously incorporated into 
most of the cells' microtubules. 
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Figure 3-6. Post-translationally modified alpha-tubulins in HA~-tubulin infected cardiocytes. Plated 
cardiocytes were treated for 18 hours with one of the HA~-tubulin adenoviruses at an MOl of 2000. 
Total protein was isolated 3 days after infection and Western blots were performed with a monoclonal 
~-tubulin antibody and the three alpha tubulin anti]Jodies described in the text. Cells that had not been 
infected with adenovirus were used as a control. 
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the BI isotype in adult cardiocytes in vitro does not have an effect on microtubule 
stability. 
Since it is possible that 3 days of exogenous tubulin expression does not give the 
cell enough time to show an observable difference in the levels of post-translationally 
modified a-tubulins, or that there was some technical difficulty with the antibodies, we 
wanted to use other means to look at microtubule stability in infected cardiocytes. For 
this we used two previously established confocal methods that we had used to prove that 
microtubules are stabilized during pressure overload-induced hypertrophy (10). The first 
is treatment of cells with cold temperatures (from 4°C to goC) to see if there are changes 
in the levels of cold-stable microtubules. The second is the treatment of cardiocytes with 
nocodazole, a drug that depolymerizes microtubules, to see if there are changes in the 
levels of drug-stable microtubules. Treatment of infected and non-infected cardiocytes at 
6°C shows no difference in the level of cold-stable microtubules in HASI-infected 
cardiocytes (Figure 3-7). In addition, cells were treated at 4°C and at goC for 30 minutes 
to 2 hours and again showed no difference in the level of cold-stable microtubules (data 
not shown). A total of about 50 cells from 3 different cell preps were examined for each 
isotype and showed no qualitative difference from control cells in the appearance of the 
microtubules when treated with cold temperature. Cells were also infected with control 
virus or one of the HAB-tubulin viruses, treated with varying amounts of nocodazole for 
as long as 2 hours, fixed, and stained for HA and a-tubulin. Nocodazole caused a 
depolymerization of microtubules in all of the cardiocytes and infection with HASI 
adenovirus did not seem to change the number of drug-stable microtubules (data not 
shown). All of these studies indicate that, "at least in vitro, a high level expression of the 
BI tubulin isotype does not seem to alone cause changes in microtubule stability. 
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Figure 3-7. Cold stability of microtubules in adenovirally infected adult cardiocytes. 
Cardiocytes were plated on laminin-coated coverslips and infected for 18 hours with 
either no adenovirus (top 2 panels), the HASI adenovirus (middle 2 panels), or the 
HABIV adenovirus (bottom 2 panels). After 3 days, the cells were treated to 6°C for 1 
,hour in HEPES-buffered M199, fixed, and stained for immunofluorescence with 
antibodies to the HA tag (left panels) and a-tubulin (right panels). Compare to Figure 3-
5, which shows the non-treated cardiocyte controls from the same experiment. There is a 
reduction in the number of microtubules for all of the infected as well as control 
cardiocytes. 
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Previous studies in this lab have shown that, along with an increase in the amount 
of BI tubulin during pressure overload-induced hypertrophy, there is an increase in the 
level of the predominant fibrous microtubule associated protein in the heart, MAP 4 (10). 
For this reason, an adenoviral construct expressing a myc-tagged MAP 4 gene from the 
CMV promoter was also made in this laboratory. When cardiocytes are infected with this 
virus, they show dramatic changes in their microtubule structure (see Figure 3-8). 
Specifically, the microtubules seem to be much straighter and more brightly stained, 
possibly indicating microtubule bundling. This bundling morphology is similar to what 
has been seen in myocytes treated with Taxol in this lab and others (10) and (103). In 
addition, as shown in Figure 3-8, when cardiocytes are infected with MAP 4 
overexpressing adenovirus, their microtubules are more stable to treatment with 
nocodazole. To see if co-expression with the BI-tubulin isotype affected these changes, 
we infected cardiocytes with the HASI and the MAP 4 adenovirus. We then stained with 
antibodies to the HA and the myc tags to see if both proteins incorporate into the same 
microtubules. Figure 3-9 shows that we can easily achieve expression of the HABI-
tubulin protein as well as the MAP 4 protein and that both proteins are then incorporated 
into the same microtubules. Additionally, the expression of HASI does not affect the 
microtubule morphology unless it is in the presence of MAP4 overexpression. Studies 
that look at the cold-stability and nocodazole-stability of the microtubules in HABIIMAP 
4 co-infected cells have not yet been done. Taken together, the results show that, by these 
microscopic techniques, we see no appreciable difference in microtubule stability in the 
cells that overexpress BI-tubulin. However, the overexpression of MAP4 clearly causes 
increased microtubule stability in the adult cardiocyte. 
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Figure 3-8. Overexpression of MAP 4 in adult cardiocytes. Cells were plated on laminin-
coated coverslips and infected overnight with either the control B-gal virus or the myc-
tagged MAP 4 expressing adenovirus. The upper panels show a cell that was infected 
with the control virus, fixed, and co-stained with an antibody to the myc tag (left) and an 
antibody to a-tubulin (right panel). The middle panels show a cell that was infected with 
the MAP 4 adenovirus, fixed, and co-stained with the myc tag (left) and a-tubulin 
antibody (right). The microtubules in this cell appear straighter and more tightly bundled 
than those in the cell treated with the B-gal virus (compare the upper and middle right 
panels). The bottom panels show two cells that were infected with either the control virus 
(left) or MAP 4 virus (right), then treated with nocodazole, fixed, and stained with an 
antibody to a-tubulin. The MAP 4 overexpressing cell clearly has microtubules that are 
more resistant to the nocodazole than the control cell. 
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Figure 3-9. Co-expression of the MAP4 and HASI proteins in adult cardiocytes. 
Cardiocytes were plated on laminin-coated coverslips and infected for 18 hours with the 
HASI-tubulin adenovirus (top 2 panels), the myc-tagged MAP4 adenovirus (middle 2 
panels), or both (bottom 2 panels) at a total MOl of 5000. After 3 days, the cells were 
fixed and stained for immunofluorescence with antibodies to the HA and the myc tags. 
The microtubule density for both the MAP4-infected and the HASI and MAP4 co-
infected cardiocytes is greater than that of the HASI-infected cardiocytes. Additionally, 
the HASI and mycMAP4 proteins both seem to be incorporated into the same 
microtubules. 
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Since some of this work was done, a post-doctoral fellow in our lab, Yuji 
Ishibashi, has done more experiments that further characterize the effects of MAP 4, BI, 
and BIV overexpression in adult cardiocytes. His work showed that with several repeat 
experiments, MAP 4 overexpression was alone able to confer resistance to nocodazole 
treatment in feline cardiocytes. He showed that treatment with 0.2 JlM, 2JlM, and even 20 
p,M of nocodazole left behind stable, myc-staining microtubules in only those cells 
infected with MAP 4 adenovirus. In addition, he performed experiments in which he 
isolated the microtubule and soluble fractions (10) from cells infected with MAP 4 
adenovirus and found that, compared with control cells, there was an increased amount of 
polymerized microtubules in the MAP 4 expressing cells and a decreased amount of 
soluble tubulin. This difference was not seen in cells infected with either HASI or HABIV 
alone, and was seen in cells co-infected with HASI and MAP 4 or HABIV and MAP 4. 
These experiments are being repeated because, in cells that are already separated from the 
tissue, it is more difficult to shear the cells such that the soluble fraction is not 
contaminated with polymerized microtubules. However, there was a clear difference 
between the MAP 4 overexpressing cells and all other cells. Additionally, he infected 
cells with the HASI and HABIV adenoviruses and treated with nocodazole or cold 
temperatures, and found that there was no increased microtubule stability in the infected 
cells as indicated by Western blot with the post-translationally modified et-tubulin 
antibodies. All of these studies are further support for the data that only MAP 4 
overexpression, and not BI -tubulin overexpression, is needed for increased microtubule 
stability in the adult cardiocyte. 
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DISCUSSION 
We have demonstrated in previous experiments that there is a dramatic change in 
the pattern of B-tubulin isotype expression during pressure overload-induced hypertrophy 
(24). As discussed in previous sections of this work, we have confirmed that this change 
is likely due to the transcriptional upregulation of only certain B-tubulin genes, an 
expression pattern that recapitulates the developmental pattern seen in the heart (24). Re-
expression of embryonic isoforms of structural genes is common during cardiac 
hypertrophy. However, whether or not these changes have functional significance for the 
development of hypertrophy or heart failure is not well established. We wanted to know 
if the upregulation of the BI isotype from around 4% of the total B-tubulin protein to 
about 20% of the B-tubulin protein (24) during hypertrophy has any functional 
significance for the stability of the microtubules. 
Most of the data concerning the effect of B-tubulin isotype expressIon on 
microtubule stability has come from studies on mitotically active cells in relation to 
chemotherapy drug resistance. In these studies, most of the major isotypes of B-tubulin 
have been implicated as the cause of microtubule affecting drug-resistance in cell lines or 
tumors. This runs counter to the notion that specific isotypes would cause specific effects, 
making it difficult to know whether hypertrophic induction of BI tubulin contributes to 
increased microtubule stability. Importantly, the isotypes differ mainly in their carboxy-
terminal MAP-binding region, and the different isotypes are absolutely conserved in this 
region among species. Therefore, we hypothesized that because MAP 4 and BI-tubulin 
were upregulated coordinately, as MAPs and B-tubulin isotypes are in other cell types 
(31), that the two proteins might have an increased affinity for one another, leading to a 
synergistic effect on microtubule stability. 
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For our studies, in collaboration with F. Cabral, we first addressed the conflicting 
data concerning the supposed ability of BI-tubulin to confer a hypostable phenotype in the 
presence of Taxol resistance. We asked the simple question of whether or not BI-tubulin 
overexpression, or indeed any B-tubulin overexpression, could confer resistance to the 
microtubule stabilizing drug Taxol. These studies also allowed us to look, in an alternate 
cell system, at the effects of overexpression of normally non-expressed isotypes. Because 
BII is not normally present in CRO cells and BIVb is present in lesser amounts than BI, 
these studies confirmed that more rare isotypes can be expressed at high levels and be 
incorporated freely into the microtubules. This was an important consideration, because 
there was some question as to whether we would need dual expression of an a-tubulin to 
enable incorporation of the exogenously expressed B-tubulin. These studies show that 
overexpression of the BI, BII, and BIVb isotypes cannot confer Taxol resistance, although 
a mutated B-tubulin protein easily can. 
Although our data in CRO cells clearly showed that overexpression of wild-type 
BI tubulin protein did not confer changes in microtubule stability as seen by differences in 
drug resistance, these experiments were limited by the fact that eRO cells already 
express a high level of BI (92), leaving open the possibility that further increase in BI 
expression does not affect microtubule stability. The adult cardiocyte has the advantage 
that it expresses relatively low amounts of BI, so that changes in microtubule stability 
caused by dramatic increases in BI levels should be detectable. Indeed our data show that 
with overexpression by adenoviral infection, almost 100% replacement of the 
endogenous B-tubulin with HABI-tubulin can be achieved. 
The results clearly show that overexpression of BI alone does not seem to confer 
any greater microtubule stability than overexpression of BIV. Both, however, seem to 
cause greater microtubule stability when they are co-expressed with MAP 4. These 
85 
results seem to indicate that the principal cause of increased microtubule stability during 
pressure overload-induced hypertrophy is upregulation of MAP 4. Interestingly, the 
morphology of the more stable microtubules in MAP 4 overexpressing cells is similar to 
the bundled morphology of cells that are treated with Taxol, as mentioned in the Results 
section. The overexpression of MAP4 in these experiments is likely greater than that seen 
during hypertrophy, and seems to result in a more severe phenotype. The functional 
significance of these differences is unclear. 
There still exists, of course, the possibility that no differences were observed in 
microtubule stability during these experiments because of the presence of the HA tags at 
the carboxy termini of the expressed proteins. The carboxy-terminus of the tubulin 
proteins project out from the microtubule, as shown by the crystal structure of the 
polymer (104); this region of the molecule is the binding region for fibrous MAPs. 
Because the tubulin isotypes differ significantly in this area, it has long been 
hypothesized that different isotypes might have different MAP binding affinities and 
therefore subtly alter microtubule stability. An increased ability to bind MAPs would be 
the most likely way that increased expression of BI-tubulin could alter microtubule 
stability. Therefore, an HA tag that interfered in any way with MAP binding could mask 
the effects of BI-tubulin expression. Several lines of evidence indicate, however, that this 
is not so. The HA-tagged proteins freely incorporate into microtubules, seemingly 
without interference to normal morphology of the microtubules. Additionally, when the 
HA-tagged proteins are co-expressed with MAP 4, antibodies to both proteins freely co-
decorate the same microtubules, as seen in Figure 3-9. Since the HA-tagged tubulins 
nearly replace the entire endogenous B-tuaulin pool, it seems unlikely that MAP 4 would 
be able to bind the microtubules in these cells if the HA tag did indeed interfere with 
MAP 4 binding. This is especially pertinent considering the fact that overexpression of 
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the HA-tagged tubulins in no way affected the ability of MAP 4 to stabilize the 
microtubules. Finally, while it is unclear that changes in microtubule function would be 
apparent in quiescent cardiocytes overexpressing HA-tagged tubulins, our work in CHO 
cells shows that the functionality of the microtubule network is unchanged by HA-tagged 
proteins (69). This would seem highly unlikely if the proteins were unable to bind 
endogenous MAPs to a degree that would mask any real effects that overexpression of 
the isotypes might confer. However, to completely rule out the possibility that the HA-tag 
is somehow masking a phenotype, future studies in this lab include looking at 
microtubule stability in cardiocytes infected with adenoviruses encoding the non-tagged 
forms of the BI - and BIV - tubulin proteins. 
While these immunofluorescence studies are all qualitative measures of changes 
in microtubule stability and cannot completely rule out the possibility of subtle changes 
in microtubule stability from BI-tubulin overexpression, they are good indicators that 
MAP 4 is the key player causing changes in microtubule stability during hypertrophy. 
Former studies in this lab have shown that the kind of increased microtubule stability that 
is seen during pressure overload-induced hypertrophy is easily detected qualitatively with 
immunofluorescence microscopy in cells that are given microtubule depolymerizing 
treatments. Technical difficulties have thus far precluded a thorough quantitative 
assessment of microtubule stability, but ongoing studies include improved isolation of 
microtubule and soluble tubulin fractions from cells infected with adenovirus and the 
comparison of microtubule/soluble tubulin ratios in normal cells versus cells infected 
with either HASI, HASIV, or MAP 4 constructs. The finding that overexpression of BI 
does not cause marked increase in microhibule stability, at least not to as great of degree 
as MAP 4 overexpression, brings forth the question of why does BI-tubulin 
overexpression occur. It is possible, as others have proposed in the past, that the 
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expression of certain isotypes is simply part of a tissue-specific developmental plan (25, 
105), and that the different isotypes have developed to widen an organism's adaptive 
ability (22). The possibility that the BI-tubulin gene is an innocent bystander in the heart 
cell's recapitulation of development during hypertrophy will be discussed more fully later 
in this work. 
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CHAPTER 4: OVEREXPRESSION OF THE BETA TUBULIN MUTANTS 
INTRODUCTION 
This chapter focuses on the work that was done to explore the effects of 
mutagenesis of the B-tubulin protein on microtubule stability. It had its genesis in the 
desire of this laboratory to produce models of decreased or increased microtubule 
stability in the heart of an animal that can be subjected to surgical manipulation. The 
work was done in collaboration with Fernando Cabral who has previously described 
CHO cell lines resistant to the microtubule poisons Taxol and colchicine (79). In these 
cells, the freel polymerized tubulin ratio is decreased if the cell is resistant to colchicine 
and increased if the cell is resistant to Taxol (79). In other words, colchicine-resistant 
cells have hyperstable microtubules and Taxol-resistant cells have hypostable 
microtubules. These cells have mutations in their a- and B-tubulin genes that obviously 
interfere with the proteins' ability to assemble like wild-type proteins (78). These tubulin 
mutants can prove to be valuable tools not only for the study of the regions of the u- and 
B-tubulin molecules important for microtubule assembly and stability but also for the 
study of the effects of changes in microtubule stability on different cell systems. 
Recently, the structure of the aB tubulin heterodimer was determined by electron 
crystallography of zinc-induced tubulin sheets (104). The authors then docked this 
structure into a model of the 3D map of a microtubule using data from previous studies 
(106). The data show that the a- and B-tubplin molecules are almost identical in structure 
and have 3 domains: an N-terrninal GTP binding domain, a smaller second domain, and a 
predominantly helical C-terminal domain (104). The exchangeable GTP in the B-tubulin 
molecule is oriented towards the plus end, or growing end, of the microtubule, and the 
non-exchangeable GTP bound to the a-tubulin molecule is oriented towards the minus 
end, or fixed end (106). On the outside surface of the microtubule, there are deep grooves 
in between the protofilaments, and the C-terminal helices of the tubulin proteins define a 
shallow zigzag path on the crest of each protofilament (106). The inside surface of the 
microtubule contains several long loops, some of which form the Taxol-binding pocket 
(104, 106). The models of the aB-tubulin heterodimer and the microtubule itself show 
that the longitudinal interactions between the two molecules that make up the 
heterodimer are stronger than the longitudinal interactions between the heterodimers, 
especially towards the microtubule lumenal surface (106). The y-phosphate on the 
exchangeable GTP bound to the B-tubulin molecule participates in the interaction 
between heterodimers, so when it is lost (loss of the GTP cap that is normally found at 
the end of the microtubule by GTP hydrolysis) the protofilaments curl outward and 
literally peel away from the structure, causing microtubule disassembly (107). Hydrolysis 
of the exchangeable GTP could also probably lead to destabilization of the interaction at 
the lateral interface between protofilaments by changing the confirmation of the loop 
involved in binding between protofilaments (106). 
Now that the structure of the aB-tubulin heterodimer and microtubule have been 
so well characterized, the use of mutational analysis of the tubulin proteins is attractive 
for the resolution at a fine level of the residues involved in the important functions of the 
microtubule as well as in the determination of the microtubule structure and dynamic 
instability. The finding of natural mutations of the tubulin proteins that seem to alter 
assembly dynamics is an important find in the context of resolving the structure-function 
relationships of the tubulin molecules. Work in F. Cabral's lab has revealed that there is a 
cluster of mutations in the B-tubulin molecule that causes decreased stability of the 
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microtubules in the Taxol-resistant cells which express the mutant proteins. Remarkably, 
sequence analysis of these mutations has revealed that they are found in three leucine 
residues that are clustered together near the Taxol binding site of the B-tubulin protein 
and the point of both longitudinal interactions with the a-tubulin protein and lateral 
interactions between protofilaments (93). The finding of these mutations provides 
important clues about residues that modulate microtubule dynamics. To further 
characterize the ability of these mutants to directly alter microtubule stability, we 
collaborated with Dr. Cabral and made constructs that expressed the mutant proteins for 
overexpression in CHO cells. In addition, we used these mutants as tools for the 
exploration of microtubule stability and its affect on cardiocyte function. Our specific 
aims were as follows: to determine if overexpression of these B-tubulin mutants could 
directly cause decreased microtubule stability as measured by Taxol resistance, and, if so, 
to genetically alter mice to overexpress these mutants specifically in the heart. We can 
ultimately use this model to determine if changes in microtubule stability can ameliorate 
the effects of pressure overload-induced hypertrophy at the whole heart level. 
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METHODS 
Construction of Plasmids. The pTOPneoHABI vector (see chapter 3 methods) and its 
mutant derivatives were used for all transfections. Site-directed mutagenesis was carried 
out using the Quickchange Site-Directed Mutagenesis kit (Stratagene) according to 
manufacturer's protocol. 
Transfection. Plasmid DNA was isolated using the QIAfilter Plasmid Maxi Kit (Qiagen, 
Valencia, CA) and transfected into CHO cell line tTApuro 6.6, obtained by transfecting 
wild-type CHO cells with pTOPpuro-tTA (see chapter 3 methods). Transfections were 
carried out using Lipofectamine (Gibco BRL) and 1 JAg of plasmid DNA according to the 
manufacturer's instructions except that 1 JAg/ml tetracycline (Sigma) was included at each 
step to inhibit expression of the cDNA until the time of analysis. Stable transfectants 
were isolated and maintained in medium containing 2 mg/ml G418 (Gibco BRL) plus 1 
JAg/ml tetracycline, or 0.2 JAg/ml Taxol with no tetracycline. 
Western blotting of CHO cell extracts. This was described in the methods section of 
chapter 3. 
Immunofluorescence of CHO cells. Immunofluorescence with the HA tag antibody was 
described in the methods section of chapter 3. For double label experiments, mouse 
monoclonal 6-1lB-l (Sigma), specific for acetylated a-tubulin, was added together with 
rabbit antibody HAll (Berkeley Antibody Co., Richmond, CA), specific for the HA tag. 
This was followed with a mixture of goat affinity purified and cross absorbed antibodies 
consisting of Oregon Green conjugated antirabbit IgG and Rhodamine Red-X-conjugated 
antimouse IgG (both from Molecular Probes). 
Drug resistance. The ability of B-tubulm mutations to confer Taxol resistance was 
evaluated in 2 ways. In the first, stably transfected cell lines expressing mutant HABI-
tubulin were seeded at approximately 100 cells/well in replicate wells of a 24-well dish 
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containing increasing concentrations of Taxol. The assay was carried out in duplicate 
with only one set containing 1 JLglml tetracycline. After 6-7 d, the medium was removed 
and the resistant colonies were stained with a solution of 0.1 % methylene blue as 
previously described (88). In a second assay, aliquots (-7 X 104 cells for selective and 
...... 100 cells for non-selective conditions) from total transfected cell populations were 
seeded into duplicate 6-well dishes containing normal medium (non-selective), 2 mg/ml 
G418, or 0.2 J-tg/ml Taxol, each with or without 1 p,g/ml tetracycline. After the 
appearance of visible colonies (6-7 d), one duplicate dish was stained with methylene 
blue and colonies were counted. Cells in the second dish were trypsinized and replated 
onto glass coverslips for immunofluorescence observation. 
Measurement of tubulin polymerization. The distribution of tubulin between the soluble 
and polymerized pools was measured using a previously published procedure (79). 
Briefly, cells were incubated for 2 generations (24 h) in [3H]methionine to label the 
proteins to steady state, the cells were lysed with a microtubule stabilizing buffer, 
microtubules were separated from soluble tubulin by centrifugation, a constant amount of 
[35S]methionine labeled CHO cell extract was added to each fraction, the proteins in each 
fraction were separated by 2D gel electrophoresis, and the 3H135S ratio for B-tubulin was 
determined by liquid scintillation counting of spots excised from the gels. This method 
gives very accurate and reproducible measurements of the fraction of tubulin in the 
assembled state (79). 
Making of transgenic mice. We received as a gift from Fernando Cabral a vector 
containing the wild-type cDNA for hamster BI tubulin with a C-terminal HA tag 
(pBlskHABI) (86). We used PCR-based· site-directed mutagenesis to make the 
appropriate point mutations in the wildtype BI for two of these Taxol-resistant mutants. 
The mutations made were a leucine to histidine at position 215 and leucine to arginine at 
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position 217, corresponding to the Tax 4-9 and Tax 6-9 mutants in (79), respectively. We 
then used site-directed mutagenesis to remove the Not I site just 3' to the HA tag, and 
another round of site-directed mutagenesis to introduce a 3' Sal I site. After sequencing 
to ensure no unwanted mutations were introduced into the coding sequence, we 
subcloned the HA-tagged mutants into the Sal I site of a a-MHC promoter vector (kindly 
provided by Michael Kern, Medical University of South Carolina, Charleston, SC). This 
vector contains the full a-MHC upstream region, as well as part of the a-MHC promoter 
and the entire intergenic region between the two (108). It also has, just downstream of the 
multicloning region, the 3' UTR and polyadenylation site of the human growth hormone 
eDNA. These two a-MHC/tubulin mutant constructs were linearized with Not I to 
remove all prokaryotic vector sequence, and the resulting 7.5 kb fragments were isolated 
from a 0.7% agarose gel using the JETsorb gel isolation kit (Genomed, Research Triangle 
Park, NC). The DNA was then microinjected into eggs that were implanted into 
pseudopregnant female FVB mice at the Medical University of South Carolina transgenic 
mouse facility or the University of Cincinnati transgenic mouse facility. To screen for 
transgenic offspring, DNA was isolated from tail biopsies using the QIAamp tissue kit 
(Qiagen). PCR was then performed with two sets of primers: one that specifically 
amplified a 450 bp fragment of the human growth hormone 3' UTR (present only in the 
transgene) and one that specifically amplified a 300 bp fragment of the endogenous 
mouse thyroid stimulating hormone gene (109) (to confirm the PCR reaction). Positive 
mice were confirmed with Southern blot analysis using a probe specific for the 3' UTR of 
the growth hormone gene. 
Western blotting o/transgenic mouse tissue. Protein was isolated from tissue as described 




Previous studies have yielded Taxol-resistant CHO cells that have diminished 
microtubule assembly (110-112). Several of these clones were analyzed by 2D gel 
migration and it was determined that 6 of them had alterations in the migration pattern of 
B-tubulin (93). The BI tubulin gene was cloned from these 6 clones, as well as 7 others 
that showed no alteration in the B-tubulin 2D electrophoretic pattern. The genes were 
sequenced and all of the 6 and 3 of the 7 showed mutations in their BI tubulin gene (93). 
Table 4-1 summarizes the alterations that were found as well as the determination of the 
level of polymerized tubulin protein in each cell line. In addition, Table 4-1 notes 
whether each clone is simply Taxol-resistant or Taxol dependent (110, 111, 113). This 
latter phenotype is easily recognized by a failure of the cells to divide when Taxol is 
omitted from the growth medium, and is characterized by a change in morphology to 
large multinucleated cells (114). Particularly noteworthy is the observation that Taxol 
dependent mutants have a lower extent of microtubule assembly than wild-type or 
resistant cell lines, suggesting that Taxol dependent cells are not fundamentally different 
from resistant cells. Rather, they simply have tubulin mutations that are more disruptive 
to microtubule assembly. Thus Taxol resistance mutations produce a spectrum of 
alterations in microtubule assembly from minimally disruptive (resistant cells) to highly 
disruptive (dependent cells). As shown in Table 4-1, the mutated B-tubulin genes from 
the Taxol-resistant clones showed a concentration of mutations in a small region. All the 
mutations were found in 3 leucine residues, L215, L217, and L228. 
To prove that the B-tubulin mutations discovered could directly cause alterations 
in microtubule stability, we recreated the-L215H, L217R, and L228F mutant cDNAs in 
wild-type BI tubulin cDNA containing a HA tag and transfected into CHO cells. We 
circumvented the possibility that overexpression of these mutant genes might be toxic to 
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Table 4-1. Summary of B-tubulin mutations in Taxol-resistant CHO cells 

















































aFor the upper series of mutants, codons 215 and 217 are underlined. For the lower series, 
codon 228 is underlined. Mutations are indicated in bold letters. 
~he fraction of total tubulin assembled into microtubules was determined as described in 
(79). 
CR, cells are resistant to Taxol and grow without the drug. D, cells are resistant to Taxol 
but also require the continuous presence of the drug for cell division. 
d Although this cell line has the same"" mutation as Tax 1-4 and Tax 4-9, its properties, 
including Taxol dependence, differ significantly from the other mutants. We suspect that 
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this cell line may have a second mutation in another gene because of its extremely low 
reversion frequency (110). 
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transfected cells by inserting the altered tubulin cDNAs into a pTOPneo vector that 
places the gene to be expressed under the control of a minimum CMV promoter whose 
activity requires the binding of a tetracycline regulated transactivator to an upstream 
bacterial tetO sequence (87). Each of the mutant cDNAs, as well as an unmodified HABI-
tubulin, was transfected into a CHO strain (tT A/puro 6.6) that produces the tetracycline-
regulated transactivator in the absence, but not the presence, of tetracycline. 
Stable G418-resistant cell lines from each of the transfections were isolated and 
screened for production of HA tagged B-tubulin by immunofluorescence. Approximately 
half of the cell lines for each transfection proved to be positive (data not shown) and for 
each clone, >95 % of the cells in the population stained positive for HABI -tubulin 
production (data not shown). To obtain a more quantitative estimate for the fraction of 
total B-tubulin represented by the HABI-tubulin in each cell line, Western blot analysis 
with an antibody that recognizes both forms of B-tubulin was carried out (Figure 4-1). 
The HABI transfectant exhibited a very high level of HAB-tubulin production, resulting in 
a cell line in which the majority of the endogenous B-tubulin is replaced by the epitope 
tagged tubulin at steady state. The HABIL217R and HABIL228F transfectants also had high 
production of HAB-tubulin, but the endogenous B-tubulin remained a significant 
component. The lowest level of HAB-tubulin was found in the HASIL215H transfectant, 
where it accounted for only a small fraction of the total B-tubulin in the cell. In all 4 
cases, production of HA tagged tubulin was undetectable by immunofluorescence or 
Western blot analysis when the cells were grown in tetracycline (data not shown). 
Although all transfectants producing wild-type HABI-tubulin grew well in the 
absence of tetracycline, transfectants producing moderate to high levels of mutant HASI-
tubulin grew poorly. These latter cells frequently exhibited extensive multinucleation 
during interphase, and there was a clear increase in the number of mitotic cells indicating 
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Figure 4-1. Production of wild-type and mutant HAf3I-tubulin in transfected cell lines. The stably 
transfected cell lines were maintained in tetracycline ("+" lanes) or were incubated 24 h in medium 
without tetracycline ("-" lanes) and cellular proteins were then resolved by SDS gel electrophoresis, 
transferred onto nitrocellulose, and probed with antibodies specific for f3-tubulin and actin. Shown in 
the figure are <;=ells transfected with HAf3I (lanes 1 and 2), HAf3IL215H (lanes 3 and 4), HAf3IL217R (lanes 
5 and 6), and HAf3IL228F (lanes 7 and 8). Note that the HA tag causes HAf3I-tubulin (HAf3) to migrate 
more slowly than endogenous f3-tubulin (f3). An antibody to actin was included to indicate relative 
protein loading. 
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a block in mitosis. These observations are consistent with the reduced tubulin assembly 
measured in the mutants listed in Table 4-1. To further demonstrate that incorporation of 
mutant HABI -tubulin destabilizes cellular microtubules, an HABIL215H transfected cell 
population was selected in 0418 and double stained with antibodies to the HA tag and to 
acetylated a-tubulin. Work in other laboratories has demonstrated that acetylated tubulin 
is found in the most stable and least dynamic microtubules in the cell (115, 116). We 
predicted that incorporation of mutant HABI-tubulin would cause microtubule 
destabilization and lead to reduced a-tubulin acetylation. The 0418-selected population 
from cells transfected with HABIL215H was approximately 50% positive for expression, a 
value we have noted in previous transfection experiments (29, 86, 117). Figure 4-2A 
shows two adjacent cells in this population, one of which was positive (small arrow), and 
the other of which was negative (large arrow), for mutant HABI-tubulin production. 
When the same cells were viewed for acetylated a-tubulin staining (Figure 4-2B), a 
reciprocal relationship was evident. The cell that expressed mutant HABI-tubulin had 
little acetylation of a-tubulin, but the cell that did not express mutant tubulin had 
abundant a-tubulin acetylation. This result supports the notion that incorporation of 
mutant HABI-tubulin produces less stable microtubules. 
Measurement of drug resistance using a standard cloning efficiency assay was 
complicated by the observation that clones producing moderate to high levels of mutant 
HABI grew poorly and produced many multinucleated cells. This problem was 
circumvented in 2 different ways. The first came from an observation that, among the 
multinucleated cells, there were some cells that still looked normal. This suggested that 
some of the cells in the population migHt be expressing lower amounts of the mutant 
tubulin and might be able to survive when cultured without tetracycline. To select these 
cells, clones transfected with mutant HABI-tubulin were incubated in tetracycline-free 
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Figure 4-2. Cells expressing HA~IL215H have reduced a-tubulin acetylation. A G418 selected popula-
tion of cells transfected with HA~IL215H cDNA was grown 24 h without tetracycline and stained for 
immunofluorescence with antibodies to the HA tag (A) and to acetylated a-tubulin (B). Small arrows 
indicate a cell that expressed the mutant HA~I-tubulin. Large arrows indicate a neighboring cell that 
failed to express the mutant HA~I-tubulin. Note !hat acetylation was greatly reduced in the cell that 
expressed the mutant ~I-tubulin. 
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medium containing a concentration of Taxol (0.2 Jlg/ml) that is lethal to wild-type cells. 
Multiple individual colonies were selected and tested for their dose response to Taxol. 
HABI, HABIL215H' HABIL217R, and HABIL228F expressing cells were all tested for Taxol 
sensiti vity in the presence or absence of tetracycline. It was found that the HABI 
transfected cells had the same sensitivity to Taxol regardless of whether the HABI tubulin 
is expressed (no tetracycline) or not expressed (with tetracycline) (data not shown). The 
cells transfected with mutant HABI-tubulin also had wild-type Taxol sensitivity when 
grown with tetracycline, but exhibited clear resistance to the drug when mutant tubulin 
production was induced by growing the cells without tetracycline (data not shown). 
To rule out the possibility that we may have biased the results by examining 
specific clones of mutant HABI-tubulin expressing cells, we also tested the relative 
abilities of 0418 and Taxol to select mutant HABI-tubulin positive cells from the total 
transfected cell populations. We reasoned that Taxol should be a powerful agent for 
selection of mutant HABI-tubulin expressing cells if, and only if, the mutant tubulin is 
capable of conferring resistance to the drug. To test this prediction, aliquots from an 
HABIL215H transfected cell population were grown under 6 different conditions: normal 
medium, medium containing 2 mg/ml 0418, and medium containing 0.2 Jlg/ml Taxol, 
each in the presence or absence of 1 Jlg/ml tetracycline. UsHfg the number of colonies . . 
obtained under nonselective conditions (normal medium containing tetracycline) as a 
control, the relative cloning efficiencies under the various selective conditions are 
summarized in Table 4-2. The highest cloning efficiency under selective conditions was 
obtained with 0418 in the presence of tetracycline. This was expected because, under 
these conditions, HABIL215H cDNA is nBt expressed and, therefore, transfected cells 
should be capable of expressing the neomycin resistance gene without suffering negative 
consequences of HABIL215H-tubulin production. The efficiency using 0418 under inducing 
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+ Tetracycline -Tetracycline 
1 0.98 
1.3 X 10.3 (100) 7.9 X 10-4 (60) 
1.4 X 10.5 (1) 2.3 X 10-4 (18) 
CHO cell line tT Apuro 6.6 was transfected with HABIL215H eDNA. At 24 h post-
transfection, the cells were trypsinized and replated in normal medium (aMEM), medium 
containing 2 mg/ml G418, or medium containing 0.2 jlg/ml Taxol, all either in the 
presence or absence of 1 Jlg/ml tetracycline. After 6-10 d (when visible colonies were 
seen) the cells were stained with methylene blue and the surviving colonies were counted. 
The cloning efficiency was calculated as the number of colonies obtained under selective 
conditions (G418 or Taxol) divided by the number of colonies obtained under 
nonselective conditions (aMEM + tetracycline). Numbers in parentheses are the number 
of colonies obtained relative to G418 + tetracycline which was arbitrarily set at 100. 
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conditions (no tetracycline) was about 40% lower, consistent with the expectation that 
high expression of HABIL215H is deleterious to cell growth. To demonstrate that this is the 
correct explanation, cells selected under both conditions were compared by 
immunofluorescence using antibodies to the HA tag. The population selected in G418 
under non-inducing conditions but assayed following induction contained approximately 
50% HA-positive cells (Figure 4-3A). In stark contrast, cells selected in G418 under 
inducing conditions were fewer than 10% HA-positive and exhibited weaker 
fluorescence, indicating that only the cells with lower levels of expression were able to 
survive (Figure 4-3B). 
Selection in Taxol under inducing conditions was 5 times less efficient than in 
G418 with tetracycline (Table 4-2). This can be explained by the loss of cells that 
produce too little HABIL215H-tubulin to confer resistance or produce too much HABIL215H-
tuublin to survive. In contrast to the G418 selected cells, virtually all the cells selected in 
Taxol expressed HABIL215H-tubulin (Figure 4-3D). Thus, Taxol more consistently selected 
HABI-tubulin expressing cells, or transfected cells, than did G418; this strongly argues 
that HABIL215H tubulin confers resistance to the drug. Consistent with this interpretation, 
cells selected with Taxol under non-inducing conditions formed 18-fold fewer colonies. 
Cells selected under these conditions grew very poorly and needed to be cultured an 
additional week in order to obtain enough cells for analysis. The resultant cells (Figure 4-
3C) were <5% positive for HABIL215H-tubulin expression and exhibited weaker 
fluorescence than the cells selected under inducing conditions. Unlike the cells selected 
for Taxol resistance under inducing conditions, which repressed HABIL215H tubulin 
expression upon tetracycline addition, th~HA-positive cells selected under noninducing 
conditions remained positive regardless of whether tetracycline was present or absent 
(data not shown). These results indicated that the few cells selected with Taxol in the 
104 
Figure 4-3. Taxol selects for transfected cells that express mutant HA~I-tubulin. Cells transfected 
with HA~IL215H cDNA were selected for resistance to G418 (A, B) or Taxol (C, D) either in the 
presence (A, C) or absence (B, D) of 1 J,lg/ ml tetracycline. The total resistant cell population was 
then trypsinized and replated for 24 h in medium without tetracycline or Taxol before processing for 
immunofluorescence with an antibody specific for the HA tag. Arrows in Band C indicate cells that 
were positive for HA~IL215H-tubulin expression. App~oximately 50% of the cells in panel A, and 
100% of the cells in panel D were positive for expression. Bar = 10J,lm. 
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presence of tetracycline consisted of non-transfected cells with borderline Taxol 
resistance (and severe growth problems) and transfected cells with low, unregulated 
HABIL215H-tubulin production. 
The preceding data gave us confidence that direct selection of Taxol-resistant 
transfected cells, followed by analysis of transfected gene expression in the selected 
population, can serve as a rapid and reliable method for testing the ability of various 
mutations to confer drug resistance. Indeed, when the procedure was repeated three times 
with HABI, or with HABIG38E (a random mutation in Tax 11-3) cDNAs, no Taxol-resistant 
cells were obtained despite the selection of thousands of 0418 resistant colonies. In 
contrast, HABIL217R and HABIL228F cDNAs behaved like the HABIL215H cDNA and gave 
many Taxol-resistant colonies, all of which were positive for expression of the mutant 
gene. We conclude that HABIL215H' HABIL217R' and HABIL228F mutations are sufficient to 
confer Taxol resistance in CHO cells. 
The data generated by overexpression of the B-tubulin mutants in CRO cells gave 
us confidence that the mutant proteins could be used as tools to confer Taxol resistance to 
cells that expressed them at high enough levels. Because the original cells from which 
these mutant proteins were isolated had less stable microtubules (79), we were confident 
that the proteins could act as dominant negative regulators of microtubule stability. This 
afforded us the opportunity to alter microtubule stability in the context of in vivo pressure 
overload-induced hypertrophy to see what kinds of effects decreased microtubule 
stability could have on the development of heart failure in vivo. The mouse model of 
transverse aortic constriction would allow us to study pressure overload-induced 
hypertrophy in an animal that can be easily-genetically manipulated (118). Many other 
labs have used the a-mysosin heavy chain promoter (aMHC) to achieve relatively high 
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levels of expression of trans genes in the adult left ventricle of the mouse (reviewed in 
(119». 
We constructed plasmids that expressed two of the mutants isolated from Taxol-
resistant CHO cells from the a-MHC promoter. As detailed in the methods section, we 
used PCR-based site-directed mutagenesis to make the appropriate point mutations in the 
wildtype 131. The mutations made were a leucine to histidine at position 215 and leucine 
to arginine at position 217, corresponding to the Tax 4-9 and Tax 6-9 mutants in (79), 
respectively. The mutants were then subcloned into an a-MHC promoter vector (kindly 
provided by Michael Kern). This vector ensures expression of the cloned genes primarily 
in adult cardiac ventricular tissue (108). 
The mutant constructs were injected into FVB mouse oocytes that were implanted 
in pseudopregnant females. The L215H mutant yielded 39 possible founder mice, and the 
L217R mutant yielded 13 possible founders. When the mice were weaned, they were ear-
clipped for identification, tail biopsies were obtained, and genomic DNA was isolated. 
The DNA was analyzed by PCR for presence of the transgene (data not shown). Using 
Southern analysis with a probe specific for the human growth hormone 3' UTR, we 
confirmed that 4 of 39 and 1 of 13 possible founders for L215H and L217R, respectively, 
had taken up the transgene (Figure 4-4). 
The founder mice were then bred with wild-type FVB mice. These Fo offspring 
were also tested for transgene incorporation by PCR. Table 4-3 summarizes the 
transgenic status of the offspring. The numbers show that close to the expected 50% of 
offspring for the L215H lines #1 and #2 are positive for the transgene, whereas only 
about 1 % of the offspring for the L217R -line #1 is positive. This means that the L217R 
founder is probably a mosaic. One of the offspring for this line was bred with a wild-type 
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A 
6 14 25 29 
B 
3R 
Figure 4-4. Southern analysis of transgenic mice. Panel A shows genomic DNA digested with Bam HI 
in the first lane and Eco RI in the second lane for each mouse found positive for the transgene a-MHC/ 
HA~IL215H. Panel B shows DNA digested .with Eco RI in the first lane and Bam HI in the second lane 
for the mouse found positive for a-MHCIHA~IL215R. For each, a 600 b.p. band was expected for the 
Bam HI digestion and a 900 b.p. band was expected for the Eco RI digestion when a probe specific for 
the 3' UTR was used. The founder number is given above each pair of lanes. Mouse number 25 and 
mouse number 29 both died at about 3 weeks of age, but it is not known if this was because of expres-
sion of the transgene. Mouse number 14 founded the L215H #1 line, mouse number 6 founded the 






















FVB mouse, and the F 1 offspring were screened for the transgene with peR. From this 
mating, 23 of 42 offspring born were positive for the transgene. 
One of the transgenic offspring from the L215H #1 line was sacrificed and total 
protein was isolated from several tissues, including the left ventricle of the heart. Figure 
4-5 shows the results of Western blots performed with total protein from this mouse using 
the anti-HA antibody. Normal FVB mouse tissues were used as a control. The figure 
shows that the highest level of expression occurs in the left ventricle. Once these mice are 
bred to higher numbers, they will hopefully serve as a model for lower microtubule 
stability in the left ventricle of the heart. 
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Control a-MHC/HA~IL215H #1 
LV K B SM LV K B SM 
Figure 4-5. HA~-tubulin levels in tissue from a transgenic mouse. 'Total protein was isolated from 
various tissues from a non-transgenic control mouse and an L215H mutant-expressing mouse. The 
transgenic mouse was an adult male from line #1, which had the highest copy number according to 
Southern blot analysis. The proteins were subjected to Western blotting with the HA tag antibody. The 
tissues were as follows: LV=left ventricle, K=kidney, B=brain, and SM=skeletal muscle. There is a low 
amount of expression in the brain as well as the LV. 
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DISCUSSION 
Previous studies have clearly shown that there are B-tubulin mutants present in 
Taxol-resistant cells that have hypostable microtubules (79). However, these studies are 
the first direct proof that expression of the mutant tubulin proteins can directly confer 
Taxol resistance. The most striking finding of these studies, however, is that of 9 mutant 
B-tubulins cloned and sequenced, all the amino acid substitutions changed one of 3 
leucine residues that were within 14 amino acids of one another. An alignment of 8-
tubulin sequences in GenBank indicates that the 3 leucine residues are invariant with the 
exception of an isoleucine for leucine substitution at amino acid 217 in 
Schizosaccharyomyces pombe. Furthermore, the conservation of leucines at 215 and 228 
extends to cx- and y-tubulin (120). It is possible that these residues are important for 
interactions between different tubulin proteins. 
The recent publication of the crystal structure of the tubulin molecule (104) 
indicates that mutations in codons 215 and 217 are in a loop connecting helices H6 and 
H7, while the 228 mutation falls within the H7 helix itself (see Figure 4-6 for placement 
of the mutated residues within the B-tubulin molecule). While this is in the region of the 
B-tubulin protein reported to bind the Taxol molecule, it is distinct from the residue L275 
that forms the main interaction with the taxane ring (104). Mutations isolated from Taxol-
resistant CHO cells have occurred with equal frequency in both u- and B-tubulin, 
whereas only the B-tubulin protein binds Taxol. In addition, many of the resistant clones 
isolated in the past have been Taxol-dependent, meaning that they must still be able to 
bind Taxol. For these reasons, we believe that the mutations conferring Taxol resistance 
do not cause decreased ability of the Taxoi to bind, but rather a weakening of the binding 
between the tubulin molecules themselves. The fact that these mutants destabilize 
microtubule assembly in the absence of the drug implies a direct effect on subunit-
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Figure 4-6. Location of mutated residues in the crystal structure of tubulin. The approximate location 
of the mutated residues is indicated by the green circles in this representation of the tubulin heterodimer 
(93). H6 and H7 are helical regions of f3-tubulin near the mutations. P, paclitaxel. 
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subunit interactions. For this reason, these mutant proteins are wonderful tools for 
studying the effects of decreased microtubule stability in different cell systems, including 
th~ adult cardiocyte. 
For this reason, we used two of these proteins to make a mouse model with 
hypostable microtubules in the heart. We successfully made 3 mouse lines. These mice 
do not display any overt physiologic abnormalities, although their spontaneous death rate 
is possibly higher than that of normal FVB mice. At least one of the lines expresses the 
transgene in the tissue of interest, the left ventricle (LV). However, it is still unknown if 
the mice express the proteins at a high enough level to affect microtubule stability, 
although it seems likely based on previous models using this promoter construct (119). 
The future plan of study for these mice is as follows. First, all lines need to be 
characterized for transgene expression by Western analysis. Second, the state of 
microtubule stability needs to be determined from adult cardiocytes isolated from these 
mice. Third, the contractile function of individual adult cardiocytes needs to be studied. 
Fourth, if the microtubules are less stable than normal controls, the mice need to be 
studied for ability to show hypertrophy and! or decreased contractility at the whole organ 
and cardiocyte level after transverse aortic banding (118). If our model of hyperstable 
microtubules causing decreased contractility during pressure overload-induced 
hypertrophy is correct, the transgenic mice should show lesser contractile dysfunction 
after banding than normal controls. Additionally, these mice could be bred with 
transgenic mice that display other forms of cardiac disease (119) to see if there is any 
therapeutic value of decreased microtubule stability in the setting of cardiac pathology. 
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CHAPTER 5: GENERAL DISCUSSION 
The results of these studies answered several questions about the regulation of B-
tubulin proteins during pressure overload-induced cardiac hypertrophy as well as 
questions concerning what factors can affect microtubule stability in both terminally 
differentiated cardiocytes as well as mitotically active cells. Although these studies 
originated with the specific task of discovering what might cause increased microtubule 
stability during hypertrophy, they also were fruitful in answering general questions about 
the kinetics of an extremely important polymer in all cell types. 
Specifically, chapter 2 addresses the hypotheses that, during pressure overload-
induced hypertrophy, certain B-tubulin genes are upregulated transcriptionally and that 
the autoregulation of B-tubulin message by free B-tubulin heterodimers does not occur. 
The results of chapter 2 show that the B-tubulin genes are regulated transcriptionally 
during pressure overload-induced hypertrophy, and that only the normally embryonically 
expressed isotypes, BI and BII, are upregulated. In addition, the autoregulation of B-
tubulin message stability by B-tubulin protein is possible in a terminally differentiated 
cell. More importantly, the results suggest that this regulatory mechanism is only invoked 
by a rapid increase in free tubulin heterodimer levels and! or a change in the free 
heterodimerl incorporated heterodimer ratio. 
Chapter 3 addresses the hypotheses that overexpression of specific B-tubulin 
isotypes in CHO cells cannot directly cal!se ,Taxol resistance, but that overexpression of 
BI -tubulin in adult cardiocytes can cause an increase in microtubule stability. The results 
show that the overexpression of specific B-tubulin isotypes, including BI, do not directly 
cause changes in microtubule stability, as measured by induction of Taxol resistance, in 
CHO cells. The results also show that overexpression of B1-tubulin in the adult 
cardiocyte, which normally has low levels of this protein, does not cause increased 
microtubule stability. Therefore, the results suggest that the primary mechanism of 
increased microtubule stability during pressure overload-induced hypertrophy is probably 
not the overexpression of the BI tubulin molecule, but rather the increased expression of 
the predominant cardiocyte microtubule associated protein, MAP 4. 
Finally, chapter 4 reveals an area of the B-tubulin molecule that is critical for the 
maintenance of microtubule stability. The results confirm that mutations in specific 
leucine residues in this H6/ H7 loop area can confer on the B-tubulin protein the ability to 
cause decreased stability of microtubules as measured by Taxol resistance in CHO cells. 
These mutations led to the development of a useful model for the generation of less stable 
microtubules in the adult heart, allowing for a direct test of the therapeutic value of 
microtubule destabilization for heart failure in vivo. 
While all of these results are important clues about how the B-tubulin protein 
might regulate microtubule stability, they leave several questions unanswered. The most 
obvious question that arises out of the results of chapters 2 and 3 is, if the upregulation of 
B1- and B1I-tubulin is not important for the increased microtubule stability seen during 
hypertrophy, then why does it occur. A more general but related question is why do 
embryonic genes get upregulated during hypertrophy. Transcriptional regulation has been 
studied in detail for many heart-specific genes during hypertrophy. Unfortunately, most 
of these studies have been carried out in a-adrenergic agonist, growth factor, or 
mechanically stimulated neonatal rat cardiocytes. This system has many advantages, 
which include the induction of genes known to be upregulated during cardiac 
hypertrophy in vivo, and an increase in cellular protein content and cell mass; however, it 
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has many disadvantages that limit its use. In particular, neonatal cardiocytes are not fully 
differentiated; therefore, the factors and signaling pathways mediating growth may be 
very different from those in the terminally differentiated adult cardiocyte. However, these 
studies have led to a host of information about how cardiac-specific genes are regulated 
in response to certain stimuli that might imitate hypertrophic stimuli. Several 
transcription factors that upregulate different genes during hypertrophy are known. One is 
TEF-l (121), which binds to the M-CAT factor that is important for heart and skeletal 
muscle expression of some genes. Another is serum response factor (SRF) (121), which 
binds to CArG elements, sequences that have high homology to the serum response 
element known to mediate regulation of some immediate early genes during hypertrophy. 
Still another is GATA-4 (122), which binds to the GATA element and is one of a family 
of transcriptional factors known to regulate cardiac-specific expression of some genes. 
While all of these factors have been implicated in cardiac specific expression of many 
different genes, no systematic studies have been done to show whether or not they 
regulate cardiac genes at specific points during development. In short, no studies to date 
that have studied transcriptional regulation of genes during hypertrophy have fully 
explained why cells that are exposed to a hypertrophic stimulus might respond by a 
recapitulation of embryonic gene expression. In addition, as discussed in chapter 2, it is 
unclear that the recapitulation of embryonic genes is a universal phenomenon during 
hypertrophy. Importantly, some reports have even demonstrated that the upregulation of 
some genes during hypertrophy is by a mechanism that is independent of those genes' 
regulation in perinatal development (123). 
The developmental regulation of tke B-tubulin genes has been studied primarily in 
neuronal cells, where the genes are regulated coordinately with both the a-tubulin and 
MAP genes. The B1- and B11-tubulin isotypes are both expressed primarily in the early 
117 
developmental stages of both the central and peripheral nervous systems, and, in the 
peripheral nervous system, axotomy results in the upregulation of the Bll-tubulin isotype 
(22). No studies to date have shown what promoter elements might be involved in the 
upregulation of the B-tubulin genes in any tissue. It seems safe to assume that the 
elements are not cardiac-specific, like many of the ones mentioned above for regulation 
of other genes during hypertrophy. However, many studies have implicated mitogenic 
signaling pathways, such as the RaslRaflMEKlERK pathway, in the stimulation of genes 
during cardiac hypertrophy that are normally expressed embryonically. It seems 
reasonable to presume that these mitogenic signals might affect such basic cellular 
components as tubulin proteins, especially in light of the fact that these genes are 
functionally important during the cell cycle. In essence, the upregulation of these genes 
might be part of a general mitogenic plan that leads not to mitosis in the terminally 
differentiated cell, but rather cell growth. 
Neurons rely heavily on their microtubule network for transport of cellular 
components down their axons and dendrites as well as for the growth of these structures. 
Neurons, like cardiocytes, are large, terminally differentiated cells and, therefore, need 
intracellular transport for growth. Microtubule stability is increased during neuronal 
differentiation (124-126); this is accompanied by a sorting of BII-tubulin into colchicine 
stable microtubules (76). Additionally, this increased use of BII-tubulin in stable 
microtubule populations coincides with the upregulation of MAP 1B, MAP2C, and tau in 
developing neurons (76). It is reasonable to speculate, then, that the different tubulin 
isotypes are important in a functional sense for modulation of microtubule structure for 
the purpose of cell growth. This is why €lur original hypothesis of increased BI-tubulin 
causing increased microtubule stability seemed so attractive. We speculate that the 
change in microtubule stability during cardiac hypertrophy is an attempt by the cell to 
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modulate microtubule dynamics to allow for increased transport of the proteins and! or 
mRNA molecules needed to manufacture new sarcomeres. Previous studies in skeletal 
muscle cells showed the importance of MAP 4 for the maintenance of microtubule 
structure needed for sarcomerogenesis (30). We presumed that the increase in BI-tubulin, 
along with the increased MAP 4, might help stabilize the microtubules needed for 
transport, similar to the way that BlI-tubulin and the neuronal MAPs seem to affect the 
microtubules needed for transport in the developing neuron. It is possible, however, that 
MAP 4 expression alone is enough to stabilize the microtubules and that the expression 
of the BI- and BII-tubulin genes is simply part of the developmental program of gene 
expression invoked by growth signals, with their overexpression having no real 
functional significance. In essence, our results show that overexpression of tubulin 
proteins of any isotypic persuasion, coupled with increased MAP4 expression, gives the 
cell the tools it needs to stabilize its microtubules. This is further supported by data that 
showed that during muscle cell development in vitro, BIV -tubulin was found in 
colchicine stable microtubules (76). 
More experiments are necessary to confirm the data. One experiment that is 
underway was discussed in chapter 3: the overexpression of the untagged BI- and BIV-
tubulin isotypes. It is possible that the HA tag interferes in some way with MAP binding 
to mask the synergistic effect of BI-tubulin and MAP 4 overexpression. However, the 
ability to coexpress HAB-tubulin and MAP 4 in the same cells without affecting MAP 4's 
ability to stabilize the microtubules makes this unlikely. We have shown that high 
overexpression of MAP 4 can lead to microtubule stabilization, but we have yet to prove 
that overexpression at a more physiologiOo'level can increase microtubule stability. Also, 
the data from overexpression studies in this work were all generated in cell culture 
systems. To definitively prove that overexpression of MAP 4 can cause increased 
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microtubule stability in vivo, transgenic mice need to be generated that have discrete 
levels of MAP 4 overexpression specifically in the heart. These studies are also currently 
underway. Finally, in order to explore the promoter elements involved in the 
transcriptional upregulation of the B-tubulin as well as MAP 4 genes, a cell culture 
system needs to be found that can mimic the changes seen in vivo. This work failed to 
find such a system because stimulated neonatal cardiocytes do not exactly mimic pressure 
overload-induced hypertrophy and we failed to homogenously differentiate serum-starved 
muscle cell lines. However, new cardiac cell lines that are transfectable are continually 
being isolated in other labs, and some of these may undergo dramatic changes in B-
tubulin isotype expression needed to study transcriptional regulation of these promoters. 
The data concerning the autoregulation of B-tubulin message generated in chapter 
2 bring about another question not answered by this study: what is the mechanism by 
which this regulation occurs and how does it distinguish between a rate and amount 
increase in the free heterodimer concentration? Careful studies done primarily in Don 
Cleveland's laboratory showed that, for both (X- and B-tubulin messages, increased 
amounts of free tubulin heterodimers led to decreased message stability. This was true 
even with the direct injection of a small amount of free tubulin heterodimers (35). Our 
data support the hypothesis that this is not true in the adult cardiocyte, because we see at 
least a two-fold increase in the steady-state levels of free tubulin heterodimers with a 
large increase of message level. However, rapid depolymerization of microtubules in the 
terminally differentiated cardiocyte resulted in decreased message stability, proving this 
hypothesis to be false. We believe this gives an important clue to the mechanism of 
autoregulation of tubulin message stability by free tubulin heterodimers. The two main 
differences between the depolymerization of microtubules in one experiment versus the 
increased expression of tubulin in the other experiment is rate of increase in free tubulin 
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heterodimers and ratio to polymerized tubulin protein. This implies that the factor that 
mediates this autoregulatory mechanism can somehow sense either the rate of protein 
increase or the comparison to polymerized protein levels. While I have no specific 
candidates in mind for what this factor may be, one useful study might be the rate-
controlled injection of free tubulin heterodimers in individual cultured cells and 
subsequent analysis of changes in mRNA levels to at least address the hypothesis of a 
rate sensitive mechanism. Then, careful analysis of proteins that are known to bind to free 
tubulin might be a next step. It would seem likely that any protein that modulates this 
control mechanism would also need to bind to mRNA or some part of the ribosomal! 
mRNA complex, since the autoregulation only occurs on actively translated tubulin 
messages. 
The data generated in chapter 4 begin to address the question of how the structure 
of the B-tubulin molecule might affect the function of the microtubule. They show that 
mutation of leucine residues in the H6/ H7 loop region of the B-tubulin molecule 
dramatically affects the stability of the microtubule polymer. However, the data don't 
answer the question of how the leucine residues that can be mutated to give Taxol-
resistance are related to the structure of the polymer. In this context, it is important to 
establish exactly what residues can be placed at these positions and in the surrounding 
areas. Both hydrophobic and charged residue substitutions at these positions gave Taxol-
resistance (93), suggesting that the charge of the amino acid is less important than the 
size. Further studies of B-tubulin molecules mutated at position 215 have shown that any 
substitution other than leucine is detrimental to microtubule stability (K. Blade, G. Bell, 
D. Menick, F. Cabral, unpublished results). This makes it likely that there is an absolute 
need for the leucine cluster in this region to ensure proper polymerization of the 
microtubule. 
121 
The presence of this cluster of leucines makes it likely that the H6/ H7 loop in 
which it occurs is important for the stability of the microtubule. For this reason, studies 
are now being done to determine what interacts with this region of the B-tubulin 
molecule. The H6/ H7 loop appears to be situated in a region where it could potentially 
interact longitudinally with a-tubulin in the next heterodimer along the protofilament, or 
laterally with a neighboring B-tubulin in the next adjacent protofilament (Fernando 
Cabral, personal communication). To determine if this is true, a method called second site 
suppressor analysis will be used. This will take advantage of the fact that a structural 
change in one subunit can often be compensated by a complimentary change in an 
interacting subunit, leading to restoration of function or assembly. Specifically, randomly 
generated mutants of a- and B-tubulin can be transfected into a Taxol-dependent cell line. 
Any recovery of Taxol sensitivity will then indicate that a compensating mutation is 
present, possibly indicating a structure-function relationship. These studies, as well as 
other mutation studies, are being done in F. Cabral's laboratory to further define the 
regions and interactions that are critical to microtubule assembly and stability. 
The primary impetus for the work in our laboratory is to discover why the 
normally compensatory mechanism of hypertrophy fails to work after continuous 
pathologic stimulation of the heart. One of the more exciting models that may help us to 
answer this question is the canine aortic banding model that self-segregates into the 
hypertrophy and failure groups. These animals only have increased microtubule stability 
when they are unable to compensate and have a small amount of hypertrophy. This leads 
us to propose that not only is microtubule densification detrimental to contractile function 
through a viscous dampening of sarcomere motion, but that it is also detrimental for the 
development of compensatory hypertrophy. It is possible that the heart, in its attempt to 
modulate microtubule dynamics by overexpressing MAP 4 to facilitate growth, is 
122 
hampering growth, possibly through the interference of transport by binding of the MAP 
4 molecules themselves. Current studies in this lab are focused on studying, hopefully in 
skeletal muscle cells, the effect of overexpression of MAP 4 on mRNA transport to 
determine if MAP 4 is detrimental to cell growth. 
These studies are simply a beginning for determining, at a molecular level, 
possible mechanisms for the clinical condition of heart failure. The data generated have 
helped focus studies of microtubule stability in the adult cardiocyte on the effects of 
MAP 4 overexpression. As such, they have opened the possibility that modulation of 
MAP 4 in the heart can be a mechanism for the relief of contractile dysfunction and lack 
of compensation found in many pathologic forms of cardiac hypertrophy. This is a novel 
approach to therapy of heart failure, a disease that causes an enormous amount of 
morbidity and mortality in man. 
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